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Abstract
This thesis has used ultra-high field (UHF) magnetic resonance imaging (MRI) to
investigate the fundamental relationships between tissue microstructure and such
susceptibility-based contrast parameters as the apparent transverse relaxation rate (R2*),
the local Larmor frequency shift (LFS) and quantitative volume magnetic susceptibility
(QS). The interaction of magnetic fields with biological tissues results in shifts in the LFS
which can be used to distinguish underlying cellular architecture. The LFS is also linked
to the relaxation properties of tissues in a gradient echo MRI sequence. Equally relevant,
histological analysis has identified iron and myelin as two major sources of the LFS. As a
result, computation of LFS and the associated volume magnetic susceptibility from MRI
phase data may serve as a significant method for in vivo monitoring of changes in iron
and myelin associated with normal, healthy aging, as well as neurological disease
processes.
In this research, the cellular level underpinnings of the R2* and LFS signals were
examined in a model rat brain system using 9.4 T MRI. The study was carried out using
biophysical modeling and correlation with quantitative histology. For the first time,
multiple biophysical modeling schemes were compared in both gray and white matter of
excised rat brain tissue. Suprisingly, R2* dependence on tissue orientation has not been
fully understood. Accordingly, scaling relations were derived for calculating the
reversible, mesoscopic magnetic field component, R2′ , of the apparent transverse
relaxation rate from the orientation dependence in gray and white matter. Our results
demonstrate that the orientation dependence of R2* and LFS in both white and cortical
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gray matter has a sinusoidal dependence on tissue orientation and a linear dependence on
the volume fraction of myelin in the tissue.
A susceptibility processing pipeline was also developed and applied to the
calculation of phase-combined LFS and QS maps. The processing pipeline was
subsequently used to monitor myelin and iron changes in multiple sclerosis (MS) patients
compared to healthy, age and gender-matched controls. With the use of QS and R2*
mapping, evidence of statistically significant increases in iron deposition in sub-cortical
gray matter, as well as myelin degeneration along the white matter skeleton, were
identified in MS patients. The magnetic susceptibility-based MRI methods were then
employed as potential clinical biomarkers for disease severity monitoring of MS. It was
demonstrated that the combined use of R2* and QS, obtained from multi-echo gradient
echo MRI, could serve as an improved metric for monitoring both gray and white matter
changes in early MS.

Keywords
myelin, iron, quantitative susceptibility mapping, apparent transverse relaxation rate
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Scope of Thesis
The following is a brief overview of each chapter contained in this thesis. Chapter One
introduces the principles, methodologies and relevance of the research studies composing
the thesis. The second chapter discusses the underlying background of MRI physics,
signal acquisition and phase processing necessary for understanding relaxometry and
susceptibility mapping. A processing pipeline for multi-echo, gradient echo-based
quantification of tissue magnetic properties (R2*, LFS, and Δχ) is then examined in the
third chapter.
Chapter Four derives from a manuscript published in the Proceedings of the
National Academy of Sciences of the United States of America (Rudko et al., PNAS,
Jan 7, 2014, 111(1), E159-167). It presents a fundamental research study utilizing
combined R2*, LFS and QS mapping with multi-echo, gradient echo MRI at high field
and ultra-high resolution. Multiple biophysical modeling schemes are compared for the
first time in both gray and white matter for excised rat brain tissue.
Chapter Five derives from a manuscript accepted for publication in the journal,
Radiology (Rudko et al., Radiology, manuscript #RAD-13-2475). It highlights a 7 T
imaging study using whole-brain, quantitative Δχ and R2* mapping for simultaneous
monitoring of iron deposition and demyelinating processes in MS patients. For the first
time, voxel based morphometry is combined with generalized linear model (GLM)
analysis to identify whole brain differences between patients and controls. The sixth and
final chapter briefly summarizes the research carried out for this thesis. It also suggests
ways of extending this research, with an emphasis on both technical developments and
clinical applications.

xvii

1

Chapter 1
Introduction
The Prize is the pleasure of finding things out.
– Richard Feynman, Quantum Man

Over the last four decades, magnetic resonance imaging (MRI) has made dramatic
progress as a non-invasive imaging modality for evaluating human tissue properties.
Advanced technological breakthroughs in MRI now enable more accurate assessment of
both the structure and function of many human organ systems. Not only is MRI being
used to diagnose a wide range of disease processes, it is also being applied to such
diverse research areas as the study of heart valve abnormalities (1), functional brain
activation (2) and autoimmune cell tracking (3).
Fundamentally, MRI uses a strong external magnetic field to generate a bulk
magnetization in the hydrogen nuclei of the human body. When these nuclei are excited
by a radiofrequency (RF) pulse, an MR signal can be detected by a receiver coil. By
adding spatially-varying, linear magnetic field gradients, images can then be
reconstructed which represent the radiofrequency signal emitted from tissues (4). For
standard MRI techniques at clinical field strengths of 1.5 and 3 Tesla (T), the
radiofrequency signal is primarily a measure of the nuclear magnetization properties of
water protons. However, in ultra-high field MRI (UHF MRI, B0 ≥ 7 T), the interaction
between the external magnetic field and the orbital electrons in biological molecules also
leads to an appreciable increase in the Larmor resonance frequency experienced by water
protons (5). This frequency perturbation can be related to the concentration of
biomolecules (6-8) and serves as a useful, quantitative MRI (qMRI) biomarker.
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In any MRI scan, the specific physical characteristics of tissue being visualized
depend on how the magnetic field is modulated during the acquisition process (9). Since
the acquisition consists of a repetitive cycle of varying magnetic field gradients and RF
pulses, the tissue magnetization undergoes a concomitant series of repetitive changes.
Essentially, the magnetization is perturbed from its natural state and then allowed to
recover to equilibrium through a process known as relaxation. This process provides the
basic contrast in MRI. The differential relaxation rates of tissues result in relative signal
differences observed in an image (10). In the section that follows, the sensitization of the
MRI signal to different tissue relaxation properties is outlined in more detail and related
to qMRI – a significant topic of discussion in this thesis.

1.1 Sensitizing the MRI signal to tissue properties
A pivotal improvement of MRI compared to other diagnostic imaging techniques such as
x-ray computed tomography (CT), positron emission tomography (PET), ultrasound and
optical imaging, is its ability to sensitize the signal to different properties of biological
tissue (10). The MRI signal is flexible enough to reflect such biophysical quantities as
tissue-specific nuclear relaxation rates (longitudinal relaxation rate: T1, transverse
relaxation rate: T2, or effective transverse relaxation rate: T2*), rate of blood flow (11),
blood oxygenation (12), water molecule self-diffusion (13), as well as tissue magnetic
and electrical properties (7, 14).
The T1 or T2–weighted contrast obtained in standard MRI methods is controlled
through the adjustment of pulse sequence timing parameters such as the duration between
successive radiofrequency (RF) pulses, or the flip angle of these pulses. This, in turn,
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results in qualitative differences in signal intensity. For example, with an external
magnetic field strength of 3 T, if contrast between gray and white matter in the human
brain is desired, one can exploit the differences in either T1 (white matter = 1100 ms, gray
matter = 1800 ms) or T2 (white matter = 70 ms , cortical gray matter = 100 ms) relaxation
characteristics of brain tissue (15).
Because of its flexibility in generating contrast, MRI is used clinically by
radiologists to confirm many soft tissue neurological disorders. However, the standard
T1- and T2-weighted images employed by radiologists do not provide true quantitative
metrics of tissue composition. They only identify relative differences in nuclear
relaxation properties (4). This is problematic when seeking to relate the MRI signal to
underlying cellular-level changes associated with either disease or normal, healthy aging.
To make MRI more predictive of underlying biology, qMRI methods have been
developed. For a qMRI parameter to be effective, it must be (i) reproducible, (ii) accurate
and (iii) specific to underlying cellular architecture (16). Reproducibility reflects the
magnitude of random errors that occur from one scan session to the next. Generally, these
should be significantly less than the natural variation of the qMRI parameter itself.
Accuracy reflects how closely a measurement is to the true value. Specificity reflects how
closely the change in the qMRI parameter reflects the change in biology of the tissue.
Two frequently employed qMRI techniques are T1 and T2 relaxometry (16). With
these two methods, specific magnetic field gradients and RF pulse combinations are used
to probe the relaxation of nuclear magnetization over time. A quantitative value of T1 or
T2 can then be assigned to each location in the brain. Relaxometry has proven valuable in
understanding such neurological conditions as cerebral edema (17), Alzheimer’s and
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multiple sclerosis (MS) (18). However, T1 and T2 relaxometry require long acquisition
times and are usually not suitable for whole-brain imaging.
This thesis examines the use of three magnetic susceptibility-based qMRI
parameters acquired using a time-efficient, multi-echo, gradient echo sequence: apparent
transverse relaxation rate (R2*), local Larmor frequency shift (LFS) and volume magnetic
susceptibility (∆χ). In all computations, standard error analysis methods are employed to
identify accuracy. In the following section, the susceptibility-based MRI parameters are
described in further detail.

1.2 Ultra-High Field (UHF) MRI and its applications to susceptibility-induced
contrast
Currently, MRI scanners at high (≥ 3 T) and ultra high-field (UHF, ≥ 7 T) offer improved
signal-to-noise ratio (SNR) and increased spatial resolution compared to standard clinical
imaging at 1.5 T. UHF MRI allows visualization of smaller structures in the human brain,
including cortical folding patterns (19) and venous vasculature organization (20). A
further advantage of UHF MRI is its increased magnetic susceptibility contrast,
particularly useful in functional MRI (fMRI) (21) and superparamagnetic iron-oxide
nano-particle (SPIO) tracking (22-24). Such applications employ the magnitude of the
complex MRI signal but disregard the phase. Recently however, it has been demonstrated
that with proper processing, the contrast observed in the MRI phase is sensitive to
relative concentration differences of such important biological substrates as myelin and
iron (6, 25).
When the human body is exposed to a strong external magnetic field, small
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differences in magnetic susceptibility between neighbouring tissues result in
perturbations of the local magnetic field (26). These perturbations give rise to a
detectable shift in the LFS, which is measurable through the complex image phase.
Notably, the linear increase in magnetic susceptibility-induced field perturbations in UHF
MRI results in higher signal-to-noise ratio (SNR) and improved contrast at higher B0
fields for phase imaging (27). Once the image phase has been unwrapped and background
magnetic field contributions have been removed, an estimate of tissue specific magnetic
susceptibility properties may be computed (7, 28, 29). The magnetic susceptibility is
calculated through a field-to-source inverse problem known as Quantitative Susceptibility
Mapping (QSM), which reveals anatomical features in the brain with unprecedented
quality. QSM also allows quantitative characterization of deep gray matter structures (7,
30), brain tumours (31) , and sub-cortical iron increases in MS (32).
Presently, the clinical applicability of QSM is hampered by challenges associated
with proper phase processing and interpretation of the QS signal (7). Numerical
instabilities in the field-to-source inverse calculation can result in streaking or blurring
artifacts which complicate quantitation (33). As well, the quality of QS maps critically
depends on the accuracy of the measured image phase. Incorrect phase values due to
blood flow, low SNR, or incomplete/inaccurate phase unwrapping produce significant
non-local artifacts (6). Several solutions to these issues are addressed in this thesis, as
well as the application of QSM in conjunction with R2* mapping to underlying tissue
biology. Additionally, the clinical applicability for MS monitoring using combined
whole-brain QS and R2* maps is described for the first time.
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1.3 Application of UHF MRI to multiple sclerosis
UHF, susceptibility-based MRI of multiple sclerosis constitutes one of the major chapters
in this thesis. Accordingly, a brief overview follows of (i) the clinical symptoms and
pathophysiology of MS and (ii) the clinical monitoring of MS using UHF MRI.
1.3.1 Clinical symptoms and pathophysiology of MS
MS is a chronic, inflammatory disease of the central nervous system (CNS)
characterized by a varied and unpredictable time course (34). It is the most common
neurological disease affecting young adults in Canada (35, 36). Although the specific
cause is unknown, it appears to involve both genetic susceptibility and triggers such as a
virus, a dysregulated metabolism or environmental factors (37, 38). In most patients, MS
consists of initial episodes of reversible neurological deficit followed by progressive
deterioration, which can become severe and result in early death (34). Evolution of the
disease produces a spectrum of clinical features that may include motor weakness,
sensory and gait disturbances, vision loss and cognitive changes (34).
Several MS disease sub-types have been characterized. These are determined on
the basis of such clinical criteria as frequency of relapses, time to disease progression,
and lesion development (39). The major MS sub-types include: relapsing-remitting MS
(RRMS, approximately 85% of cases), primary progressive MS (PPMS, approximately
10% of cases) and progressive-relapsing MS (PRMS, about 5% of cases) (34). RRMS is
characterized by unpredictable relapses followed by months to years of remission. A
fourth major sub-type, secondary progressive MS (SPMS), occurs for approximately 65%
of those with initial RRMS and is defined by a progressive neurologic decline between
attacks without definite periods of remission (34). After initial symptoms, PPMS patients
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experience no remission and symptoms steadily worsen (34). PPMS patients have steady
neurologic decline from the onset, superimposed with attacks (34, 39).
The hallmark pathophysiology of MS is damage to myelin, axons and
oligodendrocytes (37). This occurs through a multistep mechanism involving sequential
inflammation, demyelination and neurodegeneration (34). The specific autoimmune
targets are believed to be cellular components of the CNS normally inaccessible due to
their location behind the blood–brain barrier. During disease initiation, entry of
autoimmune cells (T-cells, B-cells and monocytes) through the blood brain barrier is
triggered by cytokine and chemokine signals (37). Once within the CNS, T-cells are
stimulated and retained there by resident microglia, which present antigen receptor sites
to the T-cells. Microglia are also involved in clearing away myelin debris. This results in
further T-cell/lymphocyte infiltration (34). Concurrent with the initial autoimmune
response, the inflammatory infiltrate in white matter lesions eventually includes
macrophages at the lesion centre. These are principally responsible for myelin digestion
(37, 38).
The trigger for the T-cell mediated autoimmune attack in MS is unclear.
However, it is recognized that MS consists of repeated attacks on both myelin and
oligodendrocytes via an inflammatory cascade activated repeatedly over time. The
existing knowledge of the interconnected cellular components in the cascade has already
been used to create targeted therapies aimed at reducing progression (37, 40). From an
MRI standpoint, targeted imaging of these cellular components utilizing, for example,
iron-labeled cellular MRI (23), represents a promising avenue for monitoring critical
components in the MS immune response.
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1.3.2 UHF MRI of MS
Conventional MRI employing standard T1- and T2-weighted imaging plays a key
role in diagnosing MS (41). However, neither lesion load or lesion volume derived from
these standard sequences have correlated well with clinical symptoms and scoring scales
(42). In addition, standard MRI findings have not demonstrated significant predictive
power for identifying disease progression (39). Post-mortem histopathology has revealed
the inability of standard MRI to visualize no more than a subset of the actual lesions and
damage (43).
Standard MRI pulse sequences used for monitoring MS, such as T2-weighted fast
spin echo (FSE) and fluid-attenuated inversion recovery (FLAIR), visualize only twothirds of histopathologically detectable white matter (WM) lesions and less than onetenth of cortical grey matter (GM) lesions (44). Moreover, the standard sequences are
insensitive to damage in normal-appearing white matter, which is known to have a
significant role in the onset of MS (45, 46). In contrast, susceptibility-based UHF MRI
techniques, including the LFS and QS mapping methods detailed in this thesis,
potentially offer more accurate visualization of early myelin changes in gray and white
matter not visualized on standard MRI contrasts (6, 7). This is because QSM measures
both the nuclear magnetization and the accompanying magnetic susceptibility in an
imaging voxel (47). In white matter, these physical parameters are specific to the
composition of myelin, since myelin is magnetized by an amount proportional to the
magnetic susceptibility of phospholipid molecules in the myelin bilayers. Consequently,
by using UHF MRI, QSM detects an intrinsic property that may be more closely linked
to demyelination than such other methods as T2-based relaxometry or diffusion MRI
measurements of fractional anisotropy.
Equally significant, depicting MS gray matter pathology using MRI directly
relates to how clinicians deliver treatment. For example, the identification of gray matter
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damage may serve as an improved biomarker for MS monitoring (48). Indeed, UHF T2*–
weighted MRI using 2D gradient echo imaging has already demonstrated an improved
sensitivity for detecting gray matter lesions in vivo at 7 T (48). T2*–weighted MRI has
also been used to monitor the accumulation of non-haeme iron in sub-cortical gray matter
(30, 32, 49). Iron in sub-cortical gray matter is essential for normal neuronal metabolism,
including mitochondrial energy generation and myelination. However, excessive levels
may exert oxidative stress and result in cell death. When excess iron is present,
incomplete chelation or storage results in iron catalyzing the production of hydroxyl
radicals. The production of such radicals may trigger protein denaturation, damage to
DNA or oxidation of phospholipid membranes (50). As result, monitoring the
accumulation of non-haeme iron in the basal ganglia and linking this to clinical disability
is a major area of interest in UHF MRI of MS. It is a primary focus in the fifth chapter of
this thesis.
Several qMRI metrics, including T2, T2*, magnetic field correlation (MFC) and
QSM have been proposed for monitoring basal ganglia iron in vivo. In this thesis, two of
these metrics, T2* and QSM, are examined. Recent research has demonstrated that the
apparent transverse relaxation rate (R2* = 1/ T2*) correlates well with basal ganglia iron
(27). Regional values of R2* differ significantly between CIS patients (n = 32) and MS
patients (n = 37) (51). This suggests R2* relaxometry may be a useful tool for evaluating
differential iron deposition between MS disease groups. Further, it may prove helpful for
clarifying whether regional iron accumulation contributes to MS pathology or merely
reflects an epiphenomenon.
Recently, QSM has demonstrated an increased sensitivity to changes in iron
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associated with normal aging (52) and MS (32) in basal ganglia structures compared to
R2*. This increased sensitivity results from the ability of QS to measure the mean
magnetic field perturbation in a voxel, as opposed to the signal relaxation of protons in
water molecules (25). The mean magnetic field perturbation can then be directly linked to
the amount of iron (52). However, relaxometric measures such as R2* are not specific to
the mean magnetic field. Rather, they measure the effect of intra-voxel susceptibility
gradients on phase dispersion of relaxing protons (53). In this thesis, the relative
sensitivities of R2* and QS to iron accumulation in MS are evaluated as clinically relevant
biomarkers.
The second chapter examines the underlying background of MRI physics, signal
acquisition and phase processing necessary for understanding relaxometry and
susceptibility mapping. For a complete overview of all chapters, refer to the ‘Scope of
Thesis’ section on page xvii.
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Chapter 2
Underlying Sources of MRI Contrast and Signal Formation
I canna’ change the laws of physics, Captain!
– Scottie, head engineer in Star Trek

To provide a brief background for the discussion of transverse relaxometry, LFS and QS
mapping that follows, this chapter considers the fundamental sources of the MRI contrast
and signal formation. It is partitioned into four sections. The first section describes the
physics of MRI signal formation under the influence of a strong external magnetic field
and radiofrequency (RF) pulse perturbations. The Bloch equations are then introduced as
the mathematical model describing the time-evolution of the MRI signal. This is followed
by a discussion of the basics of MR image reconstruction. Lastly, an introductory
examination of susceptibility mapping provides a background for the phase processing
pipeline presented in Chapter three.

2.1 Underlying sources of the MRI signal
In an external magnetic field such as the one produced by a superconducting MRI
magnet, atomic nuclei can be treated as magnetic dipoles possessing a magnetic moment,

µ, and an angular momentum, L. These two parameters are related accordingly (1):
[2.1]
where γ is the gyromagnetic ratio which is specific to the nucleus of interest. The most
common nucleus to be imaged in MRI is that of hydrogen bonded to oxygen in water.
Hydrogen (H1) has a gyromagnetic ratio of γ = 267.51 × 106 radians/s/T and contains a
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single positively charged proton and a negatively charged electron bound by the Coulomb
electromagnetic field (2). Under the influence of the external field of the MRI magnet,
the proton experiences a torque (1),
[2.2]
which can be related to the nuclear spin angular momentum by the equation (3):

[2.3]
→

Equation [2.3] describes the time evolution of the nuclear magnetization ( M ) and forms
the basis for the MRI Bloch equation - a first-order, linear differential equation describing
the magnetization dynamics (3):
[2.4]
In equation [2.4], Bext represents the combination of the static magnetic field and both the
magnetic field gradients (G) and RF (B1) fields (4):
∧

→

→ →∧

∧

∧

B ext = B0 k + γ G ⋅ r k + B1x i + B1y j

[2.5]

Typically, the Bloch equation is written with respect to a particular reference frame, the
most familiar of which is the frame rotating in relation to the z-axis of the scanner
coordinate system at the Larmor frequency. In this frame, the external magnetic field
becomes (4):
→

→

∧

→ →∧

∧

∧

B rot = B ext − B0 k = γ G ⋅ r k + B1x i + B1y j

[2.6]

Evaluating the Bloch equations in this reference frame is equivalent to stopping the free
precession of spins in order to isolate the dynamics of the magnetization caused by RF
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pulses and gradients. The rotating reference frame is described pictorially as follows:

Figure 2.1: (a) Classical representation of the nuclear magnetization vector, aligned
along the magnetic field in the static reference frame. (b) Schematic representation of the
reference rotating about the z-axis at the Larmor resonance frequency, (ω), of onresonant spins.

The primed coordinates (x′, y′ and z′) in figure 2.1 indicate the axes are rotating about the
z-axis at the Larmor frequency. During an MRI experiment, for signal to be detected by a
receiver coil, the magnetization vector must be rotated into the transverse (x′y′) plane (3).
This is accomplished through the application of an RF pulse (B1 field) which rotates the
magnetization into the transverse plane by an angle θ = γ B1 t (4):

Figure 2.2: Application of an RF pulse with flip angle θ = γ B1t along the x′-axis. For
such an RF-pulse the magnetization vector, M, is rotated down along the y′-axis.

19

For modeling any real MRI experiment, this simplified pictorial description must be
extended further to include the effects of magnetic fields produced by nuclear spins
whose Larmor frequency is different from that of water (off-resonance spins) (1, 3). The
magnetic field of these off-resonance spins, Boff, is not rotated into the transverse plane
but does result in spins experiencing an effective field (Be) which is the vector sum of Boff
and B1 (4). This concept is illustrated below:

Figure 2.3: Schematic representation of the magnetic field vectors applied in the rotating
frame of reference (x′, y′, z′). The B1 magnetic field is applied at an angle φ relative to the
x′-axis. Due to the presence of the magnetic field generated by off-resonance spins (Boff),
the nuclear magnetization precesses around the effective magnetic field, Be, rather than
the B1 field (1, 4, 5). The effective magnetic field is rotated away from the transverse
plane by an angle ψ.

Under the additional influence of T1 and T2 relaxation, the Bloch equation describing the
dynamics of the magnetization vector can be re-written as (6-8):

[2.7]
The first term on the right hand side of equation [2.7] accounts for the free precession of
nuclei in the external magnetic field, as well as the effects of RF and gradient pulses. The
second and third terms account for longitudinal recovery (T1) and transverse decay (T2)
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respectively (8, 9). Equation [2.7] provides a phenomenological model of MRI spin
precession and can be used to simulate the effects of an MRI pulse sequence numerically
(10, 11). This is performed by inputting realistic values of T1, T2 and proton density and
using standard numerical methods to express equation [2.7] in matrix form as follows:
⎡ ⋅ ⎤
 
⎢M x ⎥ ⎡
0
−γ G ⋅ r
−γ B1xy ⋅ y
 
⎢ ⋅ ⎥ ⎢
0
γ B1xy ⋅ x
⎢ M y ⎥ = ⎢ −γ G ⋅ r
⎢ ⋅ ⎥ ⎢γ B1xy ⋅ y −γ B1xy ⋅ x
0
⎢Mz ⎥ ⎣
⎣
⎦

⎤ ⎡ M x ⎤ ⎡ −1/T2
⎥⎢
⎥ ⎢
⎥ ⎢M y ⎥ + ⎢ 0
⎥⎢ M ⎥ ⎢ 0
⎦⎣ z ⎦ ⎣

0
−1/T2
0

0 ⎤⎡M x ⎤ ⎡ 0 ⎤
⎥⎢
⎥ ⎢
⎥
0 ⎥⎢M y ⎥ + ⎢ 0 ⎥M 0
−1/T1 ⎥⎦ ⎢⎣ M z ⎥⎦ ⎢⎣ −1/T1 ⎥⎦

[2.8]
Equation [2.8], in discretized form, can be solved repeatedly for each repetition period in
an MRI sequence by using a numerical simulation. Understanding the time-dependent
changes in the nuclear magnetization vector plays a significant role in modeling the
changes in both the magnitude and phase signal from white and gray matter in the brain –
a major topic of discussion in this thesis.

2.2 Signal detection and Fourier domain representation of the MR imaging
experiment
After the application of the RF pulse, the nuclear magnetization will precess in the
transverse plane. The resultant time-varying magnetic field produced by the precessing
magnetization generates a current in a receiver coil located in the vicinity of the sample.
This current forms the basis for the MR image (3, 5). To more thoroughly understand this
concept, consider the Fourier relationship between the time-varying current in the coil,
s(t), and the Larmor resonance frequency, ω, of nuclei:

[2.9]
For the hypothetical case of a sample consisting of only pure water, ignoring the effects
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of nuclear relaxation, the Fourier relationship between the time-domain and Fourier
domain signals can be visualized as follows:

Figure 2.4: Ideal representation of the NMR signal for a sample containing pure water
without T2-relaxation.

The signal in the time domain oscillates at the Larmor frequency, while the
corresponding frequency domain spectrum shows a peak at the Larmor frequency (5). In
MRI of tissues in the human body, however, multiple chemical compounds exist in a
single volume element (voxel) of the image. Each compound experiences a slightly
different local magnetic field, resulting in a modified Fourier domain representation (9)
that contains a spectrum of signals:

Figure 2.5: Representation of the NMR signal for a sample containing compounds whose
protons experience different local magnetic fields (magnetic environments) without
T2-relaxation. The signal in the time domain is a composite sinusoid that oscillates at a
frequency that is the sum of the frequencies of the nuclei in different chemical
environments in the sample (3). The corresponding frequency domain spectrum displays
multiple peaks – each of which represents a specific proton in a particular magnetic
environment.
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Furthermore, during any standard MRI pulse sequence, T2-based nuclear relaxation
occurs (1, 12), resulting in an exponential decay of the signal, S(t). Here the variable "t"
denotes the time after the RF pulse. The exponential decay of the signal in the time
domain corresponds to a line-broadening of the signal in the Fourier domain (1) as
illustrated below:

Figure 2.6: NMR signal for a sample of pure water subject to T2-relaxation. This results
in exponential decay of the time domain signal, S(t). The line shape of the frequency
domain signal is broadened due to the exponential T2-decay process. In the simplified
representation above, the contributions of multiple resonating species with different
Larmor frequencies are neglected.

To spatially discriminate the frequency domain signal, S(ω), at one voxel from other
voxels in an image, MRI employs linear, magnetic field gradients to modulate the
amplitude of the main magnetic field (1, 12, 13). Linear modulation of the main magnetic
field (B0 ) enables the assignment of a unique resonance frequency to each location in the
image space. The magnetic gradient field, G, is generated by a current carrying wire
wound into a solenoid which produces a linear magnetic field variation along the
direction of the main field according to the following equation:

[2.10]
The application of this gradient results in the Larmor resonance frequency of spins
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becoming proportional to their spatial location:
[2.11]
Through the linear relationship in equation [2.11] the desired amplitude of the gradient
field, G, can be calculated for a particular pulse bandwidth, with Δω representing the
range of frequencies excited by the RF pulse (1, 5, 13). For instance, for a gradient
amplitude of Gz and a desired slice thickness, ΔZ , the relationship between the spatial
location of a slice and its Larmor frequency is depicted as follows:

Figure 2.7: Linear relationship between z-dimension slice thickness (ΔZ) of an MRI
pulse sequence and the bandwidth of the RF pulse (Δω).

The MRI signal detected at a time "t" after the radiofrequency excitation pulse in
the presence of an imaging gradient is then related to the nuclear spin density by the
following Fourier relationship (12):
∞

→

S(t) = ∫ ρ ( r ) e
−∞

→

iω ( r )t

→

d r

[2.12]

→

where ρ( r ) represents the spin density of nuclei at a particular location. In the rotating
reference frame, where the Larmor frequency is removed from the signal, equation [2.12]
is expressed as:
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∞

→

S(t) = ∫ ρ ( r ) e
−∞

→

iγ G r t

→

d r

[2.13]

To express this equation in more compact form, the relationship in equation [2.13] can be

simplified (1, 5). The following change of variables is customary:
[2.14]
which, for the case of temporally-varying gradient waveforms, becomes:

[2.15]
where equation [2.15] defines the signal in the spatial frequency domain (often referred to
as k-space in MRI). The spatial frequency domain signal is related to the spin density
(ρ(r)), which is the variable of interest in MRI, through the inverse Fourier transform
operation:

[2.16]
From equation [2.16], it is clear that the relationship between the frequency domain
signal and MRI and the spatial domain spin density is through use of the inverse Fourier
transform. This relationship is represented schematically below:

Figure 2.8: Fourier relationships between the frequency domain signal and the image
space signal in MRI.
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The position at each point in k-space is related to the degree of image contrast variation at
a particular frequency (12). The center-most regions of k-space contain information about
the low spatial frequency components of the image. The outer-most regions of k-space
contain information about the high spatial frequency components of the image.

2.3 Gradient recalled echo imaging and T2* contrast
Gradient recalled echo (GRE) imaging is the preferred method for acquiring complex,
T2*-weighted data used to isolate the image phase for LFS and QS mapping (14, 15).
GRE methods encompass a relatively large class of MRI pulse sequences that do not use
spin echoes (16). They include gradient-spoiled, RF-spoiled and balanced steady-state
free precession (bSSFP) sequences (17). A standard, gradient-spoiled GRE sequence
typically consists of an RF excitation, followed by imaging gradients and data
acquisition. The sequence is repeated many times to acquire a full imaging volume.

Figure 2.9: Pulse sequence diagram illustrating a typical gradient echo imaging sequence
used in susceptibility mapping at UHF.

In figure 2.9, the echo time (TE) represents the time between the RF excitation and the
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middle of the readout gradient. The value of TE, along with the repetition interval (TR),
flip angle and spoiling method, all influence the signal in a GRE sequence. The contrast
is also influenced by the T1, T2 and T2* properties of the tissue (17). For example, when
the TR period is reduced below approximately 2 × T1, the spins do not regain complete
longitudinal magnetization following the excitation pulse and a steady-state
magnetization is reached (14, 18). In such a steady-state, the regrowth of the longitudinal
magnetization is in equilibrium with the reduction in this magnetization caused by the RF
pulse.
If GRE imaging is preferentially sensitized to the T2* relaxation rate (R2* = 1/T2*),
an image is obtained which is dominated by two parameters:(i) the rate of apparent signal
decay in an imaging voxel produced by spin-spin (R2 = 1/T2) dephasing of the transverse
magnetization (Mxy) and (ii) local magnetic field inhomogeneities (R2′ = 1/T2′) (19).
R2* = R2 + R2′

[2.17]

Mathematically, the influence of R2* on the time-dependent MRI signal, S(t), in a GRE
experiment can be understood using the static dephasing regime theory (20). In this
regime, self-diffusion of water molecules is neglected and the MRI signal, normalized to
the voxel volume, is given by:
S(t) =

1



⋅ ρ ⋅ ∫ d r ⋅ exp(−t ⋅ R2 (r )) ⋅ exp(−i ⋅ ω (r ) ⋅ t)
V
V0

[2.18]

where ρ represents the combined effects of spin density, receiver coil sensitivity and RF

excitation efficiency. The exp(−t ⋅ R2 (r )) term is proportional to the influence of R2 at a


point r in the medium. The exp(−i ⋅ ω (r ) ⋅ t) term is proportional to the influence of R2′ at


a point r in the medium and is dependent upon the geometry of the microscopic
perturbers (21). The value of the relaxation constant in a tissue can be derived from Eq.
[2.18] by integrating over the volume of interest and performing a non-linear, least
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squares fit to the resulting function:
[2.19]
where S0 represents the magnitude signal immediately after the RF pulse was applied and
t represents the time from the centre of the RF pulse to the center of the readout window.
This is schematically displayed in figure 2.10:

Figure 2.10: Schematic representation of a single repetition period for a multi-echo, GRE
sequence. The α symbols denote the excitation pulses The fitted signal decay (red curve)
corresponding to equation [2.19] and corresponding measurements points (black dots) are
overlaid on the bipolar readout gradient diagram.

GRE methods are particularly useful for fast, whole brain imaging because they
employ small RF pulse flip angles and shorter repetition times compared to conventional,
spin-echo sequences. Shorter TR periods result in an overall reduced acquisition time for
volumetric imaging. Additionally, at UHF, radiofrequency heating mitigates the
amplitude of the RF pulses that can be used. The low flip angles used in GRE imaging
allows for rapid, whole-brain imaging with UHF MRI without significant tissue heating
effects.
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2.4 Susceptibility imaging using gradient echo MRI at UHF
Having outlined the foundations of GRE imaging, a brief description of
electromagnetic theory applied to susceptibility processing now follows. This section
focuses on the basic physics of susceptibility contrast in MRI. A more detailed discussion
of processing and reconstruction techniques for susceptibility mapping is presented in
Chapter 3.
The human body contains a range of magnetic susceptibility values. Soft tissue
and bone are diamagnetically (negatively) shifted relative to water, with susceptibility
values ranging from 0 to -30 parts per billion (ppb) of the main magnetic field (22). In
contrast, iron and air are paramagnetically shifted relative to water, with susceptibility
values ranging from ~ 40 to 400 ppb. The exact susceptibility distribution in the brain,
however, is not known a priori (23). It is a function of tissue myelin, iron and protein
content,

as

well

as

chemical

exchange

and

the

microscopic

compartmentalization/geometry of water and lipid protons (24, 25).
To determine the susceptibility distribution in tissue, Maxwell’s equations are
used. According to the theory of magnetostatics, a given susceptibility distribution,
Δχ, produces a shift in the static magnetic field according to the Laplace equation (26):

[2.20]
The integral form of equation [2.20] can be written as:

[2.21]
where ΔB( ) denotes the magnetic field shift and θrr′ is the angle produced by the
projection of the long axis of the susceptibility inclusion onto the external magnetic field
(27). For simple geometries, the solution to this convolution integral is obtained by using
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a Green’s function expansion (28). From a practical standpoint, however, numerical
computation of a solution to equation [2.21] is facilitated by transforming the integral
relationship into the Fourier domain and implementing an iterative numerical solution
(29). The resulting pointwise multiplication in the Fourier domain is given by:
→
→
1 k2
F (ΔB( r )) = F ( χ ) × ( − z2 ) = F ( χ ) × Fd ( k )
3 k

[2.22]

where F denotes the Fourier transform and Fd(k) represents the Fourier transform of the
dipole convolution kernel (27). Essentially, the Fourier multiplication outlined in
equation [2.22] works by assigning a single dipole to each imaging voxel in the LFS map.
This significantly reduces the time required for the matrix inversion. However, the value
→

of the Fourier convolution kernel, Fd( k ) =

, is not defined for k = 0 (27, 29).

The consequences of such a singularity, as well as methods for dealing with the
coefficients where k = 0, are discussed further in Chapter 3.
Chapter 2 has focused on the fundamental concepts employed in QS mapping
relevant to this thesis. Both QS mapping and the associated area of electromagnetic tissue
properties mapping constitute relatively new areas of research having the potential for
multiple future applications.
The development of a processing pipeline for multi-echo gradient-echo based
quantification of tissue magnetic properties (R2*, LFS and Δχ) is discussed in Chapter 3.
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Chapter 3
Ultra-High Field MRI Susceptibility Processing
The$answer$to$the$Great$Question$…$of$Life,$the$Universe$and$Everything$$
…$is$Forty;two.$$
–!Douglas!Adams,!The$Hitchhiker’s$Guide$to$the$Galaxy$

3.1 Human brain tissue magnetic properties mapping using ultra-high field
MRI
Bulk magnetic susceptibility has long been utilized in MRI as a clinically relevant
biomarker in studies of venous vessel contrast (1) and functional magnetic resonance
imaging (2). In conventional susceptibility-based MRI methods, magnetic field perturbers
produce intra-voxel spin dephasing which leads to decreased signal in magnitude images
(3, 4). Quantitative susceptibility mapping (QSM), as documented in this thesis, is an
extension of these conventional methods. It uses both the local frequency shift (LFS –
calculated from the image phase) and the image magnitude information to reconstruct
maps of intrinsic tissue magnetic susceptibility (5, 6). QS maps are more specific to tissue
properties than conventional susceptibility-weighted imaging (SWI) because they remove
the confounding influence of non-local fields and directly measure the mean magnetic
field in each voxel. This field is proportional to the concentration of biological perturbers
(7, 8).
Calculation of QS maps requires accurate processing of the image phase from
multi-echo, multi-channel data. In particular, it requires a pipeline that accounts for (i)
channel-dependent phase offsets (9, 10), (ii) phase wraps (11), (iii) non-local background
field contributions (6) and (iv) the inverse field to source problem of calculating magnetic
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susceptibility from LFS (5, 12). In this chapter, we outline the particular phase processing
pipeline developed for QSM in this thesis. The pipeline also incorporates calculation of
the apparent transverse relaxation rate (R2*).

3.2 Phase and susceptibility map processing theory
The first step in generating QS maps from UHF MRI data is calculation of the
unwrapped image phase from the complex k-space signal. However, for an MRI coil
consisting of multiple elements, it is first necessary to perform element combination in a
phase-sensitive manner. This may be accomplished using a number of different methods
which differ in how they calculate coil sensitivities and whether or not they incorporate
these sensitivities into the combination (10). To achieve acceptable acquisition times for
whole brain imaging, channel combination generally must also be performed in
conjunction with parallel imaging (13). In the sections which follow, the theory of the
gradient echo signal received by a multi-element RF coil array is described and the
optimal, phase sensitive coil combination techniques used in this thesis are highlighted.
For a T2*-weighted gradient echo image, the magnitude of the signal (Imag) decays
exponentially as a function of the echo time (TE) and T2* (3, 4). The corresponding phase
image, φ, is the sum of the global background phase offset, ϕb0, the phase term of the B1+
field, ϕb1+, and the local phase offset due to the susceptibility of tissue, ϕχ, where ϕχ is
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expressed as:
[3.1]
The Δfχ term represents the resonance frequency shift of tissue compared to that of pure
water. When multi-element RF coils are employed, each coil-element simultaneously
receives signal from all voxels weighted by the coil-sensitivity profile (14). In this
scenario, for the mth element in the coil array, the coil-sensitivity profile can be written as
:

[3.2]

where Cmag,m and ϕm represent the element-specific magnitude and phase profiles of the
mth element, respectively (15). The signal acquired by the mth coil-element, Sm,j, is the
product of Cm and the true complex image (I)
[3.3]
or
[3.4]
where ϕb0 , ϕb1 , ϕm and ϕχ respectively represent the phase contributions from B0
inhomogeneities, B1+ transmit fields, element-specific phase offsets and tissue structure.
Element-wise coil combination based on Eq. [3.4] can be performed with or
without estimation of coil sensitivity profiles (16). In the following section, the most
common coil combination techniques are introduced and the methods used for the
experiments in this thesis are highlighted.
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3.3 Element combination with coil sensitivity map estimation
When coil sensitivity maps can be computed, combination generally proceeds using one
of two techniques: (i) reference-based SENSE (ref-SENSE) (16) or (ii) self-calibrated
SENSE (17). Reference-based SENSE requires two sets of images acquired with the
same scan parameters. First an image is acquired with a standard volume coil. This is
followed by a second image acquired using a multi-element coil. The sensitivity maps are
then calculated by complex division of the individual coil element images by the image
from the volume coil (16). Because the resulting sensitivity maps are affected by both
noise and tissue contrast, they are usually smoothed before performing channel
combination. The data from all coil elements is subsequently combined into a single
image using least-squares optimization (14).
In self-calibrated SENSE, no volume coil image is necessary. The sensitivity
profiles are derived from the complex data of each coil alone (17). The magnitude term of
the coil sensitivity is obtained by using the root of sum of squares method (18). The
phase term is then calculated either from the phase obtained from the complex sum of all
coil-elements or by phase-matching (10). The combined complex image from all
elements is then determined using least-squares optimization (17).

3.4 Element combination without coil sensitivity map estimation
At UHF, coil sensitivity profiles are generally not available because volume coils are not
utilized for signal detection (10). The standard method for combining receivers when
sensitivities are not available is to compute the square root of the sum of squares of the
signal for each channel (16, 18). However, since this method discards the phase
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information, it is unsuitable for QSM. In this case, phase sensitive coil combination can
be performed using either (i) simple global phase alignment (10), (ii) phase correction
relative to a reference coil (19), or (iii) by referencing the phase in a multi-echo sequence
to that of the first echo (Hermitian inner product method) (10). An alternative procedure,
specific to multi-echo data, is to perform a singular value decomposition (SVD) of the
complex signal (19, 20). This yields the best estimate, in the least squares sense, of both
magnetization and coil sensitivity. The two techniques employed for phase sensitive coil
combination in this thesis, the Hermitian inner product method and multi-echo SVD are
outlined below.
In the Hermitian inner product coil combination, the first echo complex image is
subtracted from all subsequent echoes. This is followed by the complex sum of the
images for all coil elements (10) as well as for all echoes (denoted by the variable ‘j’). In
this manner, the ϕm and ϕb1+ phase contributions are removed because they are static
(unchanging with echo time):

[3.5]
In Eq. [3.5], S*m,j is the complex conjugate of Sm,j and the sum is taken across channels.
In the multi-echo SVD coil combination, the individual coil element
magnetization and sensitivity profiles are simultaneously obtained using a point-by-point
SVD in the complex image domain. The SVD assumes coil elements have equal and
uncorrelated noise. For each point in the image, the coil sensitivity, C, is represented by
an N × 1 vector where N is the number of coil elements. The magnetization vector, G, is
represented by a 1 × M vector, with M representing the number of echoes.
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Consequently, the signal, S, can then be written as an N × M matrix:
S = CG

[3.6]

In reality, the signal received from most multi-channel receive coils is unequal and
uncorrelated. Consequently, S must be transformed using an estimate of the noise
covariance matrix, V, such that S = V-1S. The SVD is then be computed as follows:
S-1 = UΣVH

[3.7]

where U and V are orthogonal matrices and Σ represents a diagonal matrix of singular
values (λ). The singular values in Σ are organized such that the largest values occur at the
top left corner of the matrix. The first right eigenvector of V gives an estimate of the
magnetization. An estimate of the coil sensitivity matrix, C, is obtained from the first left
eigenector of U. The final magnetization vector, G, which is the main parameter of
interest, is obtained by scaling the first right eigenvector of V by λ1.

3.5 Calculating frequency maps from the image phase
Once the complex signal from multiple receiver coils has been combined into one
data set, the phase must be unwrapped to remove discontinuities. The wrapped phase
contains values that range between –π and π and is not usable for QSM (3). Resolving the
unwrapped phase involves adding or subtracting 2π from specific pixels located along the
phase wrap boundaries (21). This may be performed temporally, if multi-echo data are
available, or spatially if only a single-echo is acquired. In this thesis, the unwrapped
phase was obtained using a combined spatial (21) and temporal domain unwrapping
method (22, 23). The temporal unwrapping is initiated first and unwraps the phase errors
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across multiple echo times by correcting for jumps larger than ± π occuring from one
echo to the next (22). In areas of reduced phase SNR or where open-ended fringe lines
exist, temporal unwrapping is insufficient. As a result, in our processing, temporal
unwrapping is followed by a 3D spatial domain unwrapping which is a quality-guided,
path-based method that uses the wrapped phase image SNR to guide the unwrapping path
(21). By unwrapping the highest quality pixels first and the lowest quality pixels last, this
method prevents error propagation in the unwrapping process (11).
To obtain frequency maps from the resulting unwrapped phase, the phase is
temporally fit to the echo time utilizing a weighted linear regression (24). The linear
regression is weighted by the variance in the phase data to reduce noise. This variance
can be determined from the complex data, according to (25):
[3.8]

where ρ and φ are the magnitude and phase of the voxel and σ2 denotes the variance
operator. Equation [3.8] assumes the distribution of noise in the complex MRI data is
zero-mean, Gaussian. The specific formula used for the weighted linear regression is as
follows:

[3.9]

where ftot denotes the desired macroscopic frequency map and ρi and φi are the magnitude
and phase of the voxel at time ti (24). However, equation [3.9] does not hold for the case
of single-echo, gradient echo acquisitions. In the case of single-echo acquisitions, the
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macroscopic frequency shift is obtained from the following equation:

[3.10]

where the second multiplicative term on the right side of the equation [3.10] denotes the
variance weighting (3).

3.6 Background field removal
Once the macroscopic frequency maps have been reconstructed, it is necessary to
remove the influence of frequency contributions arising from air-tissue interfaces, highorder shimming, and other sources of field perturbation existing outside the brain (5). To
remove these background contributions, the macroscopic frequency variation is divided
into frequency contributions originating from sources outside the brain (fext) and those
originating from sources inside the brain (fint) according to the Sophisticated Harmonic
Artifact Reduction from Phase data (SHARP) method first proposed by Schweser et al.
(6). Accordingly, the total frequency shift at a voxel (ftot) is given by:
ftot = fint + fext

[3.11]

Determination of fint from ftot is performed using the known physical properties of the
internal and external frequency shifts. fext satisfies Laplace’s equation because it results
from sources existing outside the volume of interest (VOI):
[3.12]
Consequently, applying the Laplacian operator to ftot results in the following relationship:
[3.13]
The solution to Eq. [3.13] is calculated by applying the mean value property of harmonic
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functions (26, 27). According to this property, any harmonic function is preserved under
convolution with a non-negative, radially symmetric, normalized function (26). As it
applies to background field removal, a radially symmetric, normalized function h(r) can
be multiplied into equation [3.11] and subtracted from the original total frequency shift,
resulting in the following interim data set:
finterim = ftot – h(r) ⊗ ftot

[3.14]

One example of the convolution function is a radially symmetric spherical kernel. An
example of such a kernel for radii varying from 7 – 11 mm is illustrated below:

Figure 3.1: SHARP background filter convolution kernels with varying radii. A - C
show spherical kernels with radii of 7, 9 and 11 mm respectively.

In our specific implementation of Eq. [3.14], the convolution function, h(r), was a
spherical kernel which extended over a radius of

7 – 11 mm. A larger spherical

convolution kernel resulted in improved background field removal at the expense of
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increased erosion of pixels at the edge of the brain:

Figure 3.2: SHARP filtered LFS maps generated using an increasing spherical kernel
radius. A - C show LFS maps generated with SHARP spherical kernels of 7, 9 and 11
mm respectively. In C, background field removal is more efficient at the center of the
brain, while more regions at the edge of the brain are lost due to erosion.

Since fext obeys the harmonic mean value theorem, Eq. [3.14] can be reduced to:
finterim = fint – h(r) ⊗ fint
= (σ - h(r))⊗ fint

[3.15]

where σ represents the Dirac delta function. As a result, Eq. [3.15] can be solved to
isolate fint using a deconvolution operation:
fint =(σ - h(r)) ⊗-1 finterim

[3.16]

The values in finterim are corrupted at the edge of the VOI because the convolution is
carried out using a kernel which extends into the region outside the brain. In order to
compensate for this effect, the deconvolution of Eq. [3.16] must be limited to a region
where non-zero values of finterim exist. This results in an erosion of the phase data at the
edge of the brain by an amount equal to the radius of the convolution kernel function.
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3.7 Calculating volume magnetic susceptibility from the LFS map
According to Maxwell’s equations, the true susceptibility distribution in a tissue is related
to the internal frequency shift by the following convolution:

[3.17]
where ∆B(r) denotes the magnetic field shift and θrr’ is the angle produced by the
projection of the long axis of the susceptibility inclusion onto the external magnetic field
(28). The solution to this convolution integral over a volume is obtained in the spatial
domain by using a Green’s function expansion for simple geometries. However, in
medical imaging both ∆B(r) and χ(r’) are defined by large matrices. For practical
computation, the inversion of Eq. [3.17] in the spatial domain requires tens to hundreds
of gigabytes, if each matrix is formed explicitly (5). The computation of χ(r’) from Eq.
[3.17] can be performed more simply if the problem is formulated in the Fourier domain
(29). With this approach, the magnetic susceptibility map can be numerically calculated
from the the LFS utilizing a k-space based, regularized inversion with a conjugate
gradient algorithm. By defining the k-space representation of fL as fL(k) and the k-space
representation of Δχ as Δχ(k), the local resonance frequency map is related to the volume
magnetic susceptibility as follows (5):

[3.18]
Equation [3.18] can also be written in matrix form as:
[3.19]
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where δ denotes the k-space local frequency shift, C represents the Fourier domain dipole
convolution kernel and the variable X denotes the Fourier domain susceptibility
distribution of interest. A visual representation of the convolution function, C, in the axial
plane is given below:

Figure 3.3: Numerically-generated dipole convolution kernel employed in QSM
inversion. The kernel is displayed using: (A) a 2D view in the kz-kx (sagittal plane) and
(B) a 2D view in the kx-ky plane (axial plane). The black lines in Fig. 3.3B denote regions
of the Fourier domain where the convolution kernel has very small values. This property
of the convolution kernel makes the inversion of equation [3.18] an ill-conditioned
problem.

Calculation of QS maps from the LFS requires inversion of the linear system of equations
represented by Eq. [3.19]. Theoretically, direct inversion can be used to yield X.
However, since the dipole convolution function, C, has zeros on a conical surface defined
by 2kz2 = kx2 + ky2 (this is visually displayed by the black lines in Fig. 3.3B), a direct
inversion is ill-conditioned in areas where C is small. A common method used for
reconstruction of accurate susceptibility maps is quadratic minimization of a regularized
least-squares objective function (5, 6). For this purpose, Eq. [3.19] can be written as a
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weighted least-squares problem with spatial priors:
[3.20]

where W, W0 and W1 are weighting matrices (spatial prior information) defined as: a
binary mask of the brain in the second echo magnitude image (W0), the magnitude image
itself (W) and the gradient norm of the magnitude image (W1). These spatial priors for a
gradient echo brain image obtained from 7 T MRI are displayed below:

Figure 3.4: Spatial priors used in calculation of susceptibility maps from LFS maps.

A minimum quadratic form of Eq. [3.20] is solved using the conjugate gradient normal
residual (CGNR) method in the numerical implementation of QSM (5):
[3.21]
Previous work in our lab has revealed that optimum values of α2 and β2 = 1 × 104 are
appropriate for realistic reconstruction of susceptibility in human brain at 7 T. These
values were chosen because they resulted in the smallest log residual at the transition
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point in the L-curve. They also reconstructed constant, realistic values for susceptibility
over a range of iterative steps in the CGNR algorithm implemented in Matlab (R2013).
Accurate, reproducible QS mapping requires calculation of QS values relative to a
common reference structure. In this study, the mean QS value calculated from bilateral
ROIs in frontal deep white matter was used as a reference tissue. Frontal white matter has
previously (12) been used effectively as a reference structure in high-resolution QS
mapping at 7 T in healthy subjects.

Figure 3.5: Full processing pipeline utilized in this thesis for channel combination, R2*,
LFS and QS mapping.

3.8 R2* mapping
Exponential fitting of the MRI signal decay has been used extensively in MR research to
perform quantitative T2* and T2 mapping (30, 31). For example, nuclear-nuclear and
nuclear-electron magnetic interactions give rise to the longitudinal (T1) and transverse
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(T2) relaxation rates of water molecules used to characterize tissue properties in
quantitative MRI (32). Another relaxation-based quantitative MRI parameter often
employed to characterize tissue properties is the apparent transverse relaxation rate,
R2* = 1/T2* (3, 16). The variable R2* = R2 + R2′, with R2′ representing the contribution to
the signal relaxation rate from local magnetic field inhomogeneities. R2′ is mediated by
two major factors: (i) the difference in local magnetic field experienced by nuclei in
different magnetic environments and (ii) nuclear spin diffusion through an
inhomogeneous magnetic field (33).
If the MRI signal decay due to magnetic moment dephasing is faster than the rate
of diffusion, the signal decay due to R2* is said to be in the "static dephasing regime" or
"slow molecular motion regime" (33). In this case, the dominant contribution to R2* is the
difference in local magnetic fields experienced by nuclei and the influence of diffusion
may be neglected. In this thesis, the static dephasing regime is assumed when computing
all the susceptibility-based qMRI metrics.
The signal properties of water protons relaxing under the influence of R2* = 1/T2*
decay can be modeled for a gradient echo acquisition using the following expression:
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where TE represents the time between the RF excitation and the center of the data
acquisition and S0 identifies the magnitude signal intensity prior to any T2* decay (3). T2*
can be calculated based on equation [3.22] by measuring the decay in a gradient echo
acquisition at various time points after the RF excitation pulse. These measurements can
then be fit assuming a mono-exponential decay curve (red line in figure 2.10 of Chapter
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2). Acquisition of the decay curve at various time points is performed using either a 2D
or 3D MRI sequence. Because of its higher SNR and shorter scan time for whole-brain
imaging, 3D gradient echo imaging was employed in all work documented in this thesis.
Quantitative maps of the apparent transverse relaxation rate, R2*, were calculated
using an interior-point, least-squares fitting routine for non-linear equations. For the data
acquired in the MS imaging study, the following mono-exponential decay function:

S(TE) = S0 ⋅ exp(

γ ⋅ ΔBz ⋅ TE
TE
)
* ) ⋅ sinc(
2
T2

[3.23]

was fit to the magnitude data to account for the effects of B0 field inhomogeneity in the
R2* decay signal (34, 35). In equation [3.23], TE represents the echo time and S0
represents the signal intensity at TE = 0 ms. ∆Bz represents the gradient of the magnetic
field along the Z-direction. The ∆Bz term must be calculated independently for use in
Eq. [3.23]. The sinc term in Eq. [3.23] is applied to model the effect of B0 field
inhomogeneity on the T2* decay curve (34).
The next chapter presents a fundamental research study using combined R2*, LFS
and QS mapping with multi-echo, gradient echo MRI at high-field and ultra-high
resolution.
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Chapter 4
Origins of R2* Orientation Dependence in Gray and White Matter
Our brain – with its 100 billion neurons and quadrillion synapses, give or take a few
billion here or there – is one of the most complex entities to demystify.
– Eric J. Tople, The Creative Destruction of Medicine

4.1 Introduction
In many neurological diseases such as multiple sclerosis, Alzheimer’s and Parkinson’s,
and in conditions following traumatic brain injury, microstructural changes occur in gray
and white matter (1-4). One method for quantifying these microstructural changes is
mapping of the effective transverse relaxation rate (R2*). Along with T1 and T2, T2*
(1/ R2*) has been viewed as a fundamental MRI tissue parameter, affected by several
factors including myelin content (5, 6), endogenous ferritin-based (Fe3+) iron (7, 8), tissue
microstructure (6) and paramagnetic, blood deoxyhemoglobin (9). However, a number of
recent studies have reported a somewhat surprising dependence of R2* on tissue
orientation, at least in white matter (10-12). The purpose of this paper was to investigate
the mechanisms that could contribute to this orientation dependence of R2* in both gray
and white matter. Because R2* is influenced by magnetic field perturbations, we
examined the role of the local Larmor frequency shift (fL) and the quantitative magnetic
susceptibility (Δχ), parameters that relate field and frequency. Through this analysis we
identified novel scaling relations that relate R2′ to the local Larmor frequency shift
calculated after removal of macroscopic field inhomogeneities. Additionally, we
compared for the first time, two methods for computing Δχ in gray and white matter: (i)
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fitting the Generalized Lorentzian (GL) Model of field perturbers (13) to fL measured at
multiple brain orientations and (ii) magnitude-regularized dipole inversion (14). The
difference between these two estimates represents the local frequency shift due to a
cylindrical, axon geometry and is a marker of axonal integrity.
Having modeled the orientation dependence, we next examined the effect of
myelin and iron on both R2* and Δχ. We demonstrated a linear correlation between these
quantities and optical density (OD) derived from DAB-enhanced Perls stain (sensitive to
ferritin-based iron) for cortical gray matter. Similarly, using OD derived from
solochrome cyanine-R stained slides in rat brain major white matter fiber regions, we
showed strong positive correlations between the transverse relaxation constants, R2 and
R2′, and myelin density. Taken together, our results demonstrate that observed R2* values
in ex vivo brains can be explained by a sinusoidal dependence on tissue microstructure
orientation in conjunction with a linear dependence on the myelin concentration in
cortical gray and white matter. In deeper gray matter structures with no preferred
symmetry axis, R2* does not have an orientation dependence but retains a linear
dependence on iron concentration.

4.2 Theory
4.2.1 Orientation dependence of R 2* white matter
Recently, Lee et al. (12) used a theoretical model developed by Yablonskiy and Haacke
(15) to fit an orientation-dependence curve to R2* data from ex vivo, fixed human corpus
callosum at 7 T. The model assumes that the orientation dependence of R2* in groups of
close-packed, parallel white matter fibers can be approximated with the following
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equation:

[4.1]

where C0, C1 and ψ0 are constants and θ is the angle of the longitudinal axis of the fiber
tract relative to the B0 field. Eq. 4.1 is an extension of the standard relationship for R2* :

[4.2]

The C0 constant in Eq. 4.1 represents the conventional transverse relaxation rate, R2, as
well as any contributions to R2′ that are not angularly dependent (e.g. R2′ shifts due to
endogenous ferritin-based iron). For white matter fiber bundles, the constant C1 is defined
as
[4.3]

where the variable ζ represents the volume fraction of field perturbers and Δχ represents
the magnetic susceptibility difference between a fiber bundle and the medium
surrounding the bundle. In this paper, we validated the orientation dependence model of
Eq. 4.1 (specifically, the relation C1 = 2π ω0 ζ Δχ ) by comparing the fitted parameters
from the linear R2* model to the value of Δχ calculated from the Generalized Lorentzian
model of field perturbers (further discussed in the next section of this paper). To perform
this comparison, the OD of myelin obtained from histochemical staining and slide
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registration was used as a surrogate for the volume fraction (ζ). Throughout this paper we
define the R2′ value as being the same as C1. According to the original derivation (15),
the true value of R2′ for a network of parallel fibers is 2π ω0 ζ Δχ sin(2θ). Since we are
explicitly modeling the orientation dependence of R2′, we use the constant C1 to define
the amplitude of the R2′ variation with fiber angle. Consequently, we treat C1 as a
surrogate measure of R2′.
The orientation-dependence of the R2* signal has also been characterized with an
alternative, second-order model of field-perturbers. This model postulates that two
distinct components contribute to the orientation dependence of R2* in white matter: (i)
an isotropic component associated with the cylindrical geometry of myelinated axons
(13) and (ii) an anisotropic component associated with the phospholipid bilayer structure
of myelin (12). The equation for the second-order model is

[4.4]

In this study, we compared the linear and second-order R2* models in rat brain major
white matter fiber bundles.
4.2.2 Gray matter
Eq. 4.1 was also used to fit R2* orientation dependence in gray matter. The orientation of
gray matter was defined as the angle between the normal to the cortical surface and B0.
This technique, previously employed by Cohen-Adad (16), is physically motivated by the
fact that myelinated white matter tracts project into cortical gray matter where they
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synapse onto cortical neurons, conferring a preferred axis of symmetry in the cortical
gray matter.
4.2.3 Orientation-dependence of fL in white matter
The theoretical field shift around a susceptibility inclusion has conventionally been
calculated in NMR using the Lorentzian sphere formalism. However, this approach has
been questioned for modeling brain tissue structures such as axons that have nonspherical boundaries. Instead, an alternative Generalized Lorentzian Model (GL model)
has been suggested by He and Yablonskiy (13) for modeling field perturbers in the static
dephasing regime. This model, with application to external capsule white matter in rat
brain, is discussed in detail in what follows.
The external capsule is a large white matter tract that extends longitudinally
through the rat brain in the anterior-posterior direction. The local Larmor frequency shift
of water molecules moving inside parallel axons of the external capsule bundle relative to
the external gray matter can be calculated using the Lorentzian cylinder approximation of
He and Yablonskiy (13). In this approximation, a model Lorentzian cylinder surrounds
the white matter bundle and has a diameter larger than that of the bundle. The nuclei of
water molecules inside the axon bundle experience a frequency shift that is the
summation of the contributions from point magnetic dipoles which exist either (i) inside
or (ii) outside a Lorentzian cylinder. The magnetic field experienced by nuclei due to
dipoles existing inside the Lorentzian cylinder averages to zero because the average
magnetic field around a point dipole is zero. Consequently, the frequency shifts of the
nuclei inside the external capsule are influenced by point dipoles in the medium outside
the cylinder of Lorentz.
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Along the anterior-posterior direction, the external capsule bundle can be
considered as an infinite circular cylinder with a length significantly larger than its
diameter. In this regime, we can write the frequency shift for external capsule white
matter as:
[4.5]
where fL,WM is the local frequency shift in the white matter relative to the surrounding,
isotropic gray matter medium, χae (ppm) is the magnetic susceptibility of the isotropic
medium surrounding the axon bundle, χWM = 0.067 ppm is the magnetic susceptibility of
myelin in white matter (13) and θ is the orientation angle of an axon bundle relative to the
B0 field.
Throughout this chapter, Δχ, calculated by fitting the GL model (Eq. 4.5) to fL
measured with varying brain orientations, is denoted as ΔχGLModel to differentiate it from
the magnetic susceptibility calculated using a regularized dipole inversion method
(Δχdipole) outlined below. All magnetic susceptibility values are written in SI units and are
calculated relative to the average magnetic susceptibility in an adjacent cortical gray
matter ROI.
4.2.4 Gray Matter
We also examined the orientation dependence of fL in cortical gray matter. The presence
of cortical fibers should, theoretically, give rise to an orientation dependence described
by Eq. 4.5. We tested this hypothesis in cortical gray matter regions evenly distributed
around the cortex. The Δχ = χae - χWM term in Eq. 4.5 was replaced by Δχ = χae - χGM_average
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where χGM_average is the average susceptibility of gray matter measured from multiple ROIs
evenly distributed around the cortex.
4.2.5 Reconstruction of quantitative susceptibility maps from single-orientation fL maps
According to Maxwell’s equations, a volume magnetic susceptibility distribution, Δχ
(ppb), produces an associated local frequency shift, fL (Hz). Defining the k-space
representation of fL as fL(k) and the k-space representation of Δχ as Δχ(k), the local
resonance frequency map is related to the volume magnetic susceptibility as follows (14,
17, 18):
[4.6]
Calculation of Δχdipole maps from the fL requires inversion of Eq. 4.6. A common method
used for this inversion is quadratic minimization of a regularized, least-squares objective
function (14). The technique from (14) was employed for calculation of Δχdipole in this
work by implementing a regularized CGNR algorithm in Matlab (R2008b, The
MathWorks, Natwick, MA, USA). Calculation of magnetic susceptibility in this study
was performed using a single-orientation.

4.3 Materials and Methods
4.3.1 Measuring the orientation dependence of R2* and fL
The orientation dependence of R2* and

fL was experimentally measured in both

hemispheres of the rat brain, in white matter fiber tracts and gray matter (n=3 brains, 2
hemispheres, 18 orientations). Each rat brain was scanned with the medial fissure of the
brain oriented at 18 different sampling angles relative to the main field of the magnet.
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Specifically, each brain was rotated to (i) eight unique angles of n × 45° (n = 1…8) about
the y-axis shown in Fig. 4.1c, as well as (ii) 10 additional angles chosen to produce an
even sampling of the unit sphere. Reproducible rotations were achieved by using the
sample holder shown in Fig. 4.1.

Figure 4.1: Custom-machined sample container/experimental setup for imaging. (a)
Custom-machined sample container and (b,c) experimental setup illustrating rat brain
immersed in MRI invisible, fluorinated fluid. Each increment on the sample container
represents a ten degree rotation about the y-axis.
To improve SNR, five contiguous, 100 µm slices in each R2* and fL map were
averaged. An average R2* and fL was measured in each ROI specified in Fig. 4.2a (white
matter) and 2e,i (gray matter). The orientation of cortical fibers in each gray matter ROI
was determined by referencing to a penetrating cortical vein adjacent to, but not included
in, the ROI. These veins conveniently define the normal to the cortical surface.
Data from multiple ROIs in each sample are displayed together in Fig. 4.2(b-l).
The minimum point of each sinusoidal, orientation-dependence curve from each ROI was
phase shifted so that the vector that defined the initial orientation was effectively aligned
with the B0 field. Once the sinusoidal curves were aligned, R2* and fL data for each ROI
was averaged for the three animals.
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4.3.2 Preparation of rat brain tissue samples
Three adult, male Sprague-Dawley rats (n=3; 250-300 g) were purchased from Charles
River Laboratories (Sherbrooke, Quebec, Canada). Rat brains were excised and fixed in
4% formalin solution for two weeks prior to imaging. Fixation preserves biological
tissues from decay by preventing autolysis and halting chemical reactions. It also
increases mechanical strength of tissue in preparation for chemical staining. All animal
protocols were undertaken in accordance with Animal Care Guidelines, with approval
from the Animal Use Subcommittee of Western University.
For imaging, the brains were placed inside a 2.5 cm diameter plastic sphere filled
with

an

MR-invisible,

fluorinated

solution

(Lubrication

Technology,

Inc.,

Franklin Furnace, OH). A custom-machined, spherical sample holder allowed accurate
rotation of the brain in order to image the sample at different angles relative to the field
(Fig. 4.1a-c), while the fluorinated solution minimized the formation of susceptibilitybased edge effects in and around the brain because it has a susceptibility which is similar
to that of cortical grey matter.
4.3.3 MRI protocol
Imaging was performed on a 9.4 T, 31 cm horizontal bore animal MRI scanner (Agilent
Technologies, Santa Clara, California). An in-house designed B0 field mapping sequence,
RASTAMAP (19), was utilized to perform automated higher-order shimming before
imaging. The RF coil used for all data collection was a 4 cm diameter millipede coil
(Agilent Technologies, Santa Clara, California).
A 3D multi-echo gradient echo acquisition with an imaging field of view of 25.6 ×
25.6 × 25.6 mm3 and an isotropic resolution of 100 µm was used for imaging all brain
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orientations. The scan parameters were: TR = 50 ms, TE1 = 3.84 ms, echo spacing = 5.56
ms and 6 echoes.

4.3.4 MR image post-processing and data analysis
From the multi-echo gradient echo magnitude data, mono-exponential R2* maps were
generated using a Levenberg-Marquardt weighted least squares fitting routine. The
variance in the magnitude images was employed as a weighting term in the least-squares
fitting.
To correct for the influence of B0 field inhomogeneity, the voxel spread function
(VSF) approach was used as described in (20). The VSF method accounts for the
combined effects of both through-plane and in-plane field inhomogeneities, as well as
signal leakage from neighbouring voxels.
For registration of the data acquired with different brain orientations, the
magnitude image corresponding to the second echo at each brain orientation was coregistered to the volume acquired with the medial fissure of the brain aligned at 0°
relative to the B0 field. This was performed utilizing the FSL FLIRT tool for rigid body
affine transformations (21).
For phase processing, raw phase images were unwrapped in three-dimensions using
a region-growing algorithm (22). A Fourier filtering process was then applied to remove
background fields. First, a 3D, Gaussian, low-pass filter was applied to the Fourier
transform of the unwrapped phase data (23). The Gaussian filter had the following
functional form:
[4.7]
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The value of σ for the convolution kernel was set to 0.007 m-1. This value was chosen to
sufficiently remove background field contributions, while still preserving local frequency
contrast between gray and white matter. A 3D inverse Fourier transform was then applied
to the result of the Fourier domain multiplication to generate low-pass filtered, spatial
domain data. Subtraction of this low pass filtered data from the original, unwrapped
phase data produced a high pass filtered phase image.
After background filtering, the phase maps were fit using a weighted linear
regression to yield the off-resonance frequency at each voxel, i.e. fL (24). The linear
regression was weighted by the phase noise variances.
4.3.5 Histological staining
For histological staining, brains were prepared for sectioning using a Leica RM2255
Microtome (Cryostat Microsystems, Wetzlar, Germany) in accordance with previously
published methods (25). Sections were cut at a thickness of 5 µm and de-paraffinized
before staining by heating at 50 °C. Every second slice was then stained with solochrome
cyanine R (ScR) for myelin detection (25). The remaining slices were stained for iron
using diaminobenzidine (DAB)-enhanced Perls stain (26).
The microscopy slides were digitized using a Zeiss Axio Optical Imager (Carl Zeiss
AG, Jena, Germany) at 40× magnification. The digital images were then co-registered to
the R2* maps using the FSL FLIRT registration tool (21). Subsequently, a value for
optical density, OD = -log10(I/Io), was computed at each pixel, where I represents the
image intensity for light passing through tissue and Io represents the image intensity for
light passing through a region of the slide where only the background level of staining
was observed.
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4.4 Results and Discussion
4.4.1 Imaging setup
Each of three rat brain samples was imaged using a multi-echo, gradient echo sequence
with the medial fissure of the brain oriented at 18 different sampling angles relative to the
main field of the magnet. Specifically, the brains were rotated to (i) eight unique angles
of n × 45° (n = 1…8) about the y-axis shown in Fig. 4.1c, as well as (ii) 10 additional
angles chosen to produce an even sampling of the unit sphere. Reproducible rotations
were achieved by using the sample holder shown in Fig. 4.1.
4.4.2 Orientation dependence of R2* in white matter
Fig. 4.2b illustrates the change in R2* as a function of the orientation of the four ROIs in
the external capsule. Statistically significant changes in the white matter R2* for different
brain orientations were observed at the confidence level of p < 0.01. This significance
level was computed using a balanced one-way ANOVA for comparing independent
samples containing mutually independent observations. The orientation-dependence of
R2* was well fit by a sin(2θ + ψ0) relationship, with an average peak-to-peak variation of
ΔR2* = 3.11 ± 0.62 s-1 (averaged across all external capsule ROIs in both hemispheres).
The linear and second-order R2* models of Eq. 4.1 and 4.4 were both fit to the R2*
data in white matter. From fitting of the linear model, three parameters, C1, C0 and ψ0,
related to tissue composition (12) were then calculated. The full set of derived parameters
for all rat brains are listed in Table 4.1. To generate those values, the linear model was fit
to the data in each ROI of Fig. 4.2a for each brain sample. The fitted values for external
capsule ROIs in the same hemisphere for the same sample were then averaged. A C0
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Figure 4.2: R2* and fL changes observed in gray and white matter as a function of
fiber orientation relative to B0 (for white matter) and surface normal orientation
relative to B0 (for gray matter). The regions of interest (ROIs) used for this analysis are
displayed in Fig. 4.2 a, e and i. The ROIs used for analysis are overlaid on the second
echo magnitude image with the medial fissure of the brain oriented parallel to B0. The
linear R2* model is overlaid on Fig. 4.2b and f. The GL model fit is overlaid on Fig. 4.2c
and g. Fig. 4.2j and k demonstrate the R2* and fL changes observed in the basal ganglia
structures (lateral habenular nuclei) as a function of brain orientation. Fig. 4.2d, h and l
demonstrate the linear relationships between the orientation dependence of R2* and fL in
white and gray matter.
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Table 4.1: Parameters derived from fitting the linear R2* model in external capsule
white matter. Data is shown for each of the three brain samples (e.g. S1 = brain sample
1). Pearson correlation coefficients (r) are given in the right-most column of the table.

ROI Location

C0 (s-1)

C1 (s-1)

ψ 0 (°)

r

Left Brain, S1

59.89 ± 0.27

2.47 ± 0.37

11.74 ± 9.28

0.849

Right Brain, S1

59.36 ± 0.16

1.05 ± 0.23

32.58 ± 11.93

0.750

Left Brain, S2

64.23 ± 0.11

1.53 ± 0.11

22.84 ± 5.23

0.926

Right Brain, S2

64.71 ± 0.23

1.83 ± 0.32

21.73 ± 10.36

0.833

Left Brain, S3

62.14 ± 0.26

1.23 ± 0.39

15.23 ± 16.82

0.633

Right Brain, S3

62.47 ± 0.24

1.21 ± 0.32

21.39 ± 16.53

0.702

value of 62.13 ± 0.54 s–1 was observed when all external capsule white matter ROIs were
averaged (n=3). A two-tailed Welch’s t-test revealed no statistically significant difference
(p < 0.05) between C0 computed in the left and right brain external capsule.
The second-order model (Eq. 4.4) was also fit to the R2* orientation data in
external capsule white matter. The derived parameters are listed in Table 4.2. The
correlation coefficients in Table 4.2 demonstrate that the second-order model did not
provide significantly improved fitting. For this reason, no further analysis was conducted
with this higher-order model. Application of the higher-order model is difficult due to the
confounding contributions of residual background fields (which may also have a sin(4θ)
dependence). In previous studies, SNR considerations revealed that large ROIs are
necessary for observing the sin(4θ) component. Such large ROIs are prone to introducing
error in the measured R2* orientation dependence because the mean value of R2*
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Table 4.2: Parameters derived from fitting the higher-order R2* model in external
capsule white matter. Data is shown for each of the three brain samples (e.g. S1 = brain
sample 1). Pearson correlation coefficients (r) are given in the right-most column of the
table.

ROI Location
Left Brain, S1
Right Brain, S1

C0 (s-1)

C1 (s-1)

C2 (s-1)

ψ 0 (°)

r

59.90 ± 0.23

2.70 ± 0.33

0.88 ± 0.32

11.92 ± 5.08

0.825

59.44 ± 0.16

1.52 ± 0.34

1.32 ± 0.52

6.56 ± 3.09

0.814

Left Brain, S2

64.45 ± 0.11

1.42 ± 0.17

-0.35 ± 0.14

13.10 ± 5.45

0.642

Right Brain, S2

64.69 ± 0.23

1.82 ± 0.31

-0.55 ± 0.45

22.64 ± 8.30

0.739

Left Brain, S3

63.02 ± 0.25

1.20 ± 0.38

0.51 ± 0.33

19.84 ± 14.32

0.885

Right Brain, S3

62.47 ± 0.24

1.18 ± 0.33

0.50 ± 0.44

11.50 ± 13.03

0.742

calculated from a large ROI is more sensitive to background fields. Such fields may vary
over the length scale of the ROIs (12). Moreover, ROI-based analysis precludes voxelwise interpretation of the anisotropic component, which is the ultimate goal of fitting the
proposed second-order model.
4.4.3 Gray matter
Fig. 4.2f displays the changes in R2* of cortical gray matter as the brain was rotated. Gray
matter R2* varied sinusoidally with surface normal orientation and was well fit by the
linear model. The average trough-to-peak R2* variation in the cortex was ΔR2* = 0.94 ±
0.32 s-1 (averaged across all gray matter ROIs in both hemispheres). The parameters
derived from fitting the linear model in gray matter are listed in Table 4.3.
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Table 4.3: Results of the linear model fit to R2* in gray matter. Data is shown for each
of the three brain samples (e.g. S1 = brain sample 1). Pearson correlation coefficients (r)
are given in the right-most column of the table.
ROI Location

C0 (s-1)

C1 (s-1)

Left Brain, S1

46.36 ± 0.16

0.41 ± 0.16

18.02 ± 7.89

0.718

Right Brain, S1

45.10 ± 0.08

0.56 ± 0.07

20.50 ± 4.09

0.810

Left Brain, S2

46.88 ± 0.18

0.62 ± 0.15

13.52 ± 10.06

0.659

Right Brain, S2

47.11 ± 0.22

0.45 ± 0.27

24.19 ± 23.98

0.514

Left Brain, S3

46.68 ± 0.11

0.34 ± 0.10

31.85 ± 9.07

0.745

Right Brain, S3

46.57 ± 0.12

0.41 ± 0.09

43.16 ± 6.27

0.796

ψ 0 (°)

r

The parameter C1 was used to estimate the trough-to-peak change in R2* R2* of subcortical gray matter did not display significant changes with brain orientation (Fig. 4.2i
and j). The ROIs for this analysis were chosen in the sub-cortical, lateral-habenular
nucleus. The notable difference between Fig. 4.2f (cortical gray matter) and j (deep gray
matter) supports the premise that the orientation of penetrating cortical white matter
fibers affects estimates of mono-exponential R2* in gray matter. Further, it identifies that
changes in R2* with brain orientation in the largely isotropic structures (e.g. glial cells and
astrocytes) of the basal ganglia are insignificant. It is not possible to completely exclude
the contribution of coherently oriented microvasculature structures from the orientationdependent R2* in cortical gray matter. Further work is necessary to more completely
evaluate the quantitative contribution of cortical microvasculature to the orientationdependent R2* signal.
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4.4.4 Orientation-dependence of fL in white matter
The relationship between fL and white matter fiber orientation is illustrated in Fig. 4.2c.
The mean trough-to-peak amplitude of the fL shift was 7.2 ± 3.8 Hz. Fibers oriented
perpendicular to the B0 field had a positive frequency shift compared to those oriented
parallel to the field. This trend is characteristic of any substance that is less diamagnetic
than water. For instance, when myelin becomes less diamagnetic than water due to the
fixation process (27, 28), this trend is observed. The results are consistent with previously
observed effects of fixation on the magnetic susceptibility of myelin. The average
ΔχGLModel measured in external capsule white matter was 24.9 ± 2.25 ppb. This compares
very well to previous values of 26 ppb in mouse white matter (6).
Fig. 4.2d identifies a linear relationship between the orientation dependencies of
R2* and fL in the oriented white matter fibers of the external capsule. The specific linear
relation is given by R2* = 0.23·fL + 65.28. The influence of R2 is represented by the
vertical offset term (65.28 s-1), while a scaling constant which relates R2′ to fL is given by
the slope of the line (0.23). R2′ is influenced by the local frequency shift in a voxel for
each tissue geometry and tissue composition (15). Breaking down the respective
contributions of R2 and R2′ in this manner may be useful in identifying subtle changes
occurring in gray and white matter in the course of disease development. For instance, the
early stages of demyelination which occur prior to removal of myelin debris in multiple
sclerosis may preferentially effect R2′, while leaving R2 unchanged.
4.4.5 Gray Matter
The relationship between cortical gray matter fL and cortical fiber orientation is illustrated
in Fig. 4.2g. The data was well fit by the GL model of Eq. 4.3 The average amplitude of
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gray matter fL variation was 0.56 ± 0.13 Hz. Table 4.4 (right-most columns) shows the
values of Δχ calculated from the GL model fit. The average ΔχGLModel measured in gray
matter was 4.5 ± 1.39 ppb. Since this represents the first attempt to measure susceptibility
of gray matter using the GL model, there are no literature values with which to compare
this measurement . However, the ΔχGLModel can be compared to Δχdipole , as performed in
the section which follows. The ROIs used for this analysis of fL orientation-dependence in
cortical gray matter were chosen with reference to an adjacent intracortical vein but not
including this vein. The ROIs were specifically selected using fL maps to avoid including
local fields from large intracortical veins which can modulate fL (29).

Table 4.4: Parameters calculated from the GL model fit of fL vs. cortical surface
normal orientation (for gray matter) and fL vs. principal fiber orientation (for white
matter). The susceptibility values are referenced to the average susceptibility of
surrounding gray matter. Data is shown for each of the three brain samples (e.g. S1 =
brain sample 1). Pearson correlation coefficients (r) are given in the right-most column of
the table.

ROI Location

Gray Matter
r
Δχ (ppb)

White Matter
r
Δχ (ppb)

Left Brain, S1

2.55 ± 1.60

0.871

25.13 ± 3.77

0.780

Right Brain, S1

4.04 ± 1.96

0.734

20.11 ± 2.64

0.759

Left Brain, S2

4.46 ± 2.91

0.736

31.40 ± 5.03

0.654

Right Brain, S2

6.92 ± 2.18

0.940

27.60 ± 7.03

0.783

Left Brain, S3

3.05 ± 2.28

0.670

23.88 ± 2.89

0.895

Right Brain, S3

5.94 ± 1.89

0.840

21.36 ± 8.80

0.601
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The influence of capillary veins can also modulate an orientation-dependent fL
contrast in cortical gray matter (9). In (9) the influence of capillary deoxyhemoglobin on
fL in rat brain in-vivo was carefully measured and found to be negligible relative to the
bulk gray/white fL contrast (maximum ΔfL = 0.02 Hz for realistic values of oxygen
saturation, Y = 0.7, and hematocrit, Hct = 0.4, in rat brain capillary). Close examination
of our myelin-stained slides (see e.g. Fig. 4.5a) in the cortical ROIs, revealed the
presence of striated myelin variation across the length of the cortex but no clear evidence
of larger capillary veins. For these reasons, we believe that capillary-mediated fL shifts
negligibly contributed to the cortical gray matter orientation-dependent fL variations
observed in this study.
The orientation dependence of fL was also evaluated in sub-cortical gray matter.
Four ROIs were chosen in the left and right brain lateral habenular nuclei (Fig. 4.2i). No
distinct orientation dependence for fL (Fig. 4.2k) was observed. This result is similar to
the orientation dependence of R2* in sub-cortical gray matter and distinct from fL of
cortical gray matter which does show a subtle orientation dependence (Fig. 4.2g). This
indicates the local frequency shift is sensitive to cellular architectural differences in
different gray matter regions.
Fig. 4.2h and l identify linear relationships between the orientation dependencies of
R2* and fL for cortical and sub-cortical gray matter. For cortical gray matter, R2* = 0.82·fL
+ 49.27, while for sub-cortical gray matter, R2* = 1.10·fL + 39.51. These linear relations
identify the contribution of the local frequency shift to R2* through the R2′ value. Two
scaling relations were found: R2′ = 0.82·fL for cortical gray matter and R2′ = 1.10·fL for
sub-cortical gray matter. The scaling constant relating R2′ to fL in cortical gray matter
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(0.82) was 3.57 times larger than that of white matter (0.23). However, the mean
amplitude of the fL variation in white matter is approximately 20 times larger than that of
cortical gray matter (ΔfL = 4 Hz for white matter, compared to ΔfL = 0.2 Hz for gray
matter). Together, these factors indicate that the orientation-dependent, reversible
component of the transverse relaxation rate (R2′= constant · fL ) is approximately 5.60
times larger in white matter as compared to gray matter (for the case of this fixed rat
brain tissue). This R2′ difference is a function of the tissue microstructure because it is a
function of both axonal density and fiber orientation dispersion inside a voxel (15).
The measurement of local frequency shift through unwrapping the phase, then,
serves as an approximate alternative for measuring the orientation-dependent part of R2′
in gray matter. This may be useful for probing changes in microstructure of gray matter
associated with disease.
4.4.6 Comparison of Δχ GLModel to Δχ dipole in white matter
The histograms in Fig. 4.3a and 3b compare ΔχGLModel to Δχdipole for each sample in each
hemisphere. Table 4.4 shows the white matter susceptibility values calculated from fitting
the GL model and associated Pearson correlation values. A Welch’s two-tailed t-test
revealed that the GL model-derived and the inversion-calculated values of magnetic
susceptibility in the external capsule were different (p < 0.05) in all cases, except for the
right hemisphere of sample 3, where the mean value of ΔχGLModel is still larger than that
of Δχdipole. The difference between these two measurements was, on average, 12.73 ±
2.91 ppb. This difference results from the fact that the GL model accounts for the
geometry-induced frequency shift of cylindrical axons, whereas dipole fitting does not.
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The magnitude of the isotropic component of the frequency shift in white matter
is affected by formalin fixation. Recent research (30) conducted using excised rat brain

Figure 4.3: Comparison of Δχdipole (black bars) to ΔχGLModel (white bars) for both white
matter (Fig. 4.3a and b) and gray matter (Fig. 4.3c and d). All susceptibility values are in
SI units of parts-per-billion (ppb) and have been referenced to the susceptibility of gray
matter in an adjacent ROI. Separate comparisons were performed for left and right brain
hemispheres. Error bars represent standard error of the mean. Statistical significance
levels are defined as: * p < 0.05 and ** p < 0.001.
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optic nerve embedded in water suggests that the amplitude of this isotropic frequency
shift is increased (this is a diamagnetic shift) by a factor of approximately two, due to
fixation. For this reason, the isotropic frequency shifts reported in our paper may be
larger than those observed in fresh rat brain tissue.
The GL model does not account for susceptibility variations in white matter due
to either chemical exchange or myelin bilayer anisotropy. Nevertheless, it is a useful
model that can improve estimates of susceptibility, provided the fiber angle relative to B0
is known. Interestingly, the difference of 12.73 ± 2.91 ppb between ΔχGLModel and Δχdipole
is on the order of the isotropic magnetic susceptibility of white matter recently calculated
in mouse brain using susceptibility tensor imaging (13 ppb reported in reference (6)).
These convergent results suggest that fitting the GL model to fL measured at multiple
brain orientations is a robust technique for quantifying the isotropic, geometry-derived
component of susceptibility in white matter.
4.4.7 Gray matter
The histograms in Fig. 4.3c and d compare ΔχGLModel to Δχdipole for gray matter in each
rat brain hemisphere. The values computed for ΔχGLModel and the associated Pearson
correlation coefficients are listed in Table 4.4. A Welch’s two-tailed t-test showed that
ΔχGLModel and Δχdipole are the same in all ROIs (p > 0.05 in all cases). This is not
unexpected, since the observed variation in fL with cortical fiber orientation in this study
is very subtle (average amplitude of 0.56 ± 0.13 Hz for all ROIs examined).
From the above result, it can be inferred that, when gray matter susceptibility
information is reconstructed using dipole inversion at standard clinical field strengths and
resolutions of 1 mm3 isotropic, it is unlikely the effects of cortical fiber geometry on Δχ
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will be significant. But this may not always be true for small animal studies. As
susceptibility mapping methods improve and the achievable spatial resolution increases,
the ΔχGLModel value could serve as a standard for measurements of Δχdipole in cortical gray
matter. Such a target value would facilitate analysis of convergence in regularized dipole
inversion methods of quantitative susceptibility mapping.
4.4.8 Correlative Histology of MRI and Non-Haeme Iron in Rat Brain Basal Ganglia
Histological staining was performed to investigate the relationship between iron
concentrations in rat brain tissue and the susceptibility contrast parameters (R2* and
Δχdipole). Currently, there is significant interest in using a combination of R2* and Δχdipole
to assess none-haeme iron variations in human brain tissue (7, 26, 31). However, to date,
most studies have performed correlations between MRI susceptibility parameters in-vivo
and ex-vivo iron concentrations derived from literature (7). The quantitative relationship
between iron concentration, as derived from OD of iron-stained slides, and both R2* and
Δχdipole in the same tissue structure has not been examined.
To isolate the influence of iron on R2* and Δχdipole, ROIs were chosen in rat basal
ganglia regions containing high iron concentration and low myelin content. The ROIs
were centered on the left lateral-habenular and medio-dorsal nuclei (black boxes in Fig.
4.4a). A positive correlation (R = 0.637, p < 0.001, Fig. 4.4d) between R2* and iron OD
was observed according to the linear relation R2* = 158.05·OD + 36.72. This relation is
specific to the field strength used in this study (9.4 T) due to the dependence of R2* on
field strength. A similar positive correlation was found between Δχdipole and iron OD (R =
0.465, p < 0.001, Fig. 4.4f) with the linear regression fit: Δχdipole = 674.05·OD – 79.3. R2*
was also plotted against corresponding Δχdipole on a voxel-by-voxel basis (Fig. 4.4b) to
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Figure 4.4: R2* and quantitative susceptibility values in the lateral-habenular and mediodorsal nuclei (deep brain basal ganglia structures) of the rat brain positively correlate
with Fe3+ density from DAB-enhanced Perls staining. (a) A representative coronal section
of a rat brain stained with DAB-enhanced Perls is shown. Black boxes indicate the ROIs
in which OD and quantitative MRI values were measured. ROIs include the right and left
lateral-habenular nuclei and the right and left medio-dorsal nuclei. The corresponding
coronal MRI sections of a rat brain are displayed in (c) for R2* (in units of 1/s) and (e) for
quantitative susceptibility (in units of ppb). Figure 4b displays a positive linear
correlation between R2* and Δχdipole in the rat basal ganglia. The correlation of R2* (d) or
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Δχdipole (f) with OD measurements are also shown. Each data point represents a voxel
from the chosen ROIs. The black dotted lines indicate the linear regression fit to the data.
R and p values are indicated in the top left corner of the correlation plots.

derive a relationship between these parameters for Fe3+ iron at 9.4 T. The linear relation
between R2* and Δχdipole was R2* = 0.10·Δχdipole + 49.59, with R = 0.447 and p < 0.001.
We observed a linear correlation between R2* and Δχdipole in the rat basal ganglia
(Fig. 4.4b). In general, these two parameters need not be correlated (32); thus, this
observation sheds some light on the underlying mechanisms governing these two
quantities. Inter-voxel susceptibility differences can result in a positive or negative
frequency shift between voxels without contributing to the R2* of these voxels, while
increased intra-voxel susceptibility variation can lead to incoherent dephasing and
increased R2* in a voxel. For the case of the basal ganglia, our data suggests that punctate
non-haeme iron concentrations in the brain are accompanied by magnetic field
inhomogeneities on the scale of the voxel, thus affecting both R2* and Δχdipole.
4.4.9 Correlative Histology of MRI and Myelin Density in Rat Brain Major White
Matter Regions
In Fig. 4.5, the effect of myelin density on C0 and C1 was examined. The specific ROIs
used for this analysis are given by the black boxes in Fig. 4.5a and b. They include dense
white matter regions of the corpus callosum, external capsule and internal capsule. C0 and
C1 showed strong positive correlations with myelin OD (Fig. 4.5c and e). C0 was
correlated with myelin OD according to the relation C0 = 64.96·OD + 37.84, with R =
0.905 and p < 0.001 (Fig. 4.5c). C1 was correlated with myelin OD according to the
relation C1 = 1.62·OD + 0.94, with R = 0.456 and p < 0.001 (Fig. 4.5e). C0 and C1 were
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Figure 4.5: The constants, C0 and C1, derived from the linear R2* orientation model
correlate positively with OD of solochrome cyanine-R staining for myelin in both major
white matter tracts and cortical gray matter. (a) A representative coronal section of the rat
brain stained for myelin. (b) R2* map corresponding to the myelin stain. Black boxes
indicate the ROIs in which the OD of myelin, C0 and C1 were measured in white matter.
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Green boxes indicate the ROIs in which the OD of myelin, C0 and C1 were measured in
cortical gray matter. C0 (c,d) and C1 (e,f) correlated positively with the myelin OD in
major white matter tracts and cortical gray matter. Each data point represents a voxel
from the chosen ROIs. (g,h) Linear relations between the value of C1, calculated from
fitting the linear R2* model, and Δχ, calculated from the GL model for both white (g) and
gray (h) matter. C1 and Δχ are related through Eq. 4.3. The OD was used as a surrogate
for the volume fraction (ζ) of perturbers in these plots.

also computed in six ROIs lining the cortex (green boxes in Fig. 4.5a and b). C0 and
C1 both demonstrated strong positive correlations with myelin OD in these regions
(Fig. 4.5d and f). This supports our hypothesis that an orientation dependent R2* exists in
the cortex and the source of this dependence is associated with cortical fibers.
It is noteworthy that R2 (Co) and R2′ (C1) are affected in different ways by
changes in myelin density. R2 is governed by spin-spin interactions between
neighbouring hydrogen atoms, while R2′ is mediated by mesoscopic magnetic field
gradients both inside and between voxels. The linear relations derived from the plots in
Fig. 4.5 can be used to independently estimate myelin concentration given either R2 or
R2′. As well, they support the concept that myelin density and axonal geometry are two
major factors governing R2* changes observed with changes in fiber orientation.
According to Eq. 4.3, the constant C1, derived from fitting the linear model to the
R2* orientation data, is a linear function of Δχ. To test the validity of this model in both
white and cortical gray matter, a value of Δχ was calculated in the black and green ROIs
shown in Fig. 4.5a and b, using the GL model. The parameters C1 and OD were then
calculated in these ROIs. The OD value calculated in the ROIs was used as a measure of
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C1 and Δχ. In white matter a significant linear correlation was observed, verifying that
OD can serve as a surrogate marker for perturber volume fraction. However, in cortical
gray matter the correlation was not significant, likely due to the poorer fitting of the GL
model on a voxel-by-voxel basis in gray matter (as opposed to the case of a single mean
value from an ROI shown in Fig. 4.2g). To the best of our knowledge, this is the first
demonstration of the use of OD as a surrogate marker for volume fraction in white matter
microstructure analysis, as well as the first demonstration of a relationship between R2*
and Δχ based on the isotropic perturber model. These results suggest that, for white
matter, the combined use of R2*, Δχ and OD derived from histochemical staining can
enhance knowledge of underlying tissue composition.

4.5 Conclusion
This study demonstrates a significant orientation-dependence of R2* in both white and
cortical gray matter that is a sinusoidal function of tissue orientation and a linear function
of perturber volume fraction. The fitting coefficients, C0 and C1, calculated using the R2*
cylindrical field perturber model, are linearly related to myelin density. For white matter,
the isotropic perturber fraction, C1 , is a linear function of the white matter susceptibility
difference (Δχ) relative to gray matter. This finding supports the premise that a major
underlying source of the orientation dependence of R2* is the axonal geometry-derived
susceptibility shift.
A comparative analysis of the orientation dependencies of R2* and fL in matched
tissue locations throughout the rat brains allowed calculation of scaling relations which
quantify R2′ given

fL. Using these relations, the orientation-dependent, reversible
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component of the transverse relaxation rate (R2′= constant · fL ) was found to be
approximately 5.60 times larger in white matter compared to gray matter. Measuring such
differences in R2′ in different brain tissues is a potential method for probing tissue
microstructure, since R2′ is a function of the geometry-derived, frequency dispersion
within a voxel. Equally relevant, the identification of optical density of myelin staining as
a realistic surrogate for volume fraction in white and cortical gray matter may
complement future studies relating biophysical models of the MRI signal to true
underlying tissue composition.
The next chapter highlights a 7 T imaging study using whole-brain, quantitative
Δχ and R2* mapping for simultaneous monitoring of iron deposition and demyelinating
processes in MS patients.
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Chapter 5
Improved Identification of MS Disease-Relevant Changes in Gray
and White Matter using Susceptibility-Based High Field MRI
To make a discovery is not necessarily the same as to understand a discovery.
– Abraham Pais, Inward Bound: of Matter and Forces in the Physical World.

5.1 Introduction
Conventional magnetic resonance imaging (MRI) measures of MS disease status, using
the number and location of lesions in white matter (WM), have not correlated well with
clinical symptoms (1) or demonstrated significant predictive power for determining
disease progression (2). On the other hand, neuropathological studies have identified the
following features as being strongly related to MS etiology and neurodegeneration: (i)
changes in the chemical composition of myelin, (ii) axonal loss and (iii) accumulation of
iron in brain regions affected by MS (3). Unfortunately, it has been difficult to quantify
such neuropathological markers in vivo using standard MRI contrasts. The goal of this
study was to explore the use of quantitative susceptibility-based MRI at 7T to identify
characteristic regions suggestive of demyelination and increased iron deposition in MS
patients and relate these measurements to patient disability.
For the purposes of this research, quantitative susceptibility-based MRI consists
of the measurement of the apparent transverse relaxation rate (R2* = 1/T2*) and local
Larmor frequency shift (LFS) using a straightforward multi-echo gradient echo (GRE)
sequence. In brain tissue of MS patients, R2* values are affected by focal accumulation of
iron, as well as by transient demyelination and remyelination (4, 5). For this reason, R2*
has been proposed as a surrogate biomarker of disease severity (4). However, R2* maps
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can be inaccurate at tissue interfaces where steep magnetic field gradients exist (6).
Additionally, elevated concentrations of iron and myelin both increase R2*. This makes it
difficult to attribute R2* increases to either iron accumulation or re-myelination alone.
Disentangling the contributions of myelin and iron to the R2* signal would make it more
valuable for understanding MS pathophysiology.
Quantitative susceptibility (QS) mapping (7-9) is an MRI technique
complementary to R2* mapping that calculates tissue volume magnetic susceptibility from
the LFS. It advantageously removes the effects of confounding non-local magnetic fields
created by tissue boundaries. It is also differentially sensitive to myelin and iron (8).
Increases in myelin content (e.g. due to re-myelination) negatively shift the absolute QS
value because myelin is diamagnetic, while increases in iron content positively shift QS
because iron is paramagnetic (8). Because of this differential sensitivity, QS has the
potential to more precisely monitor disease-related changes in MS. Accordingly, the
combined use of QS and R2* obtained from multi-echo GRE MRI has been advocated as
a comprehensive method for studying brain tissue composition due to the differing
sensitivities of QS and R2* to iron and myelin (10, 11).
In this work, we used QS mapping in conjunction with mono-exponential, R2*based relaxometry to evaluate voxel-wise WM changes associated with MS disease
severity. Such a multi-parametric comparison in white matter has not previously been
performed. As a natural extension of the WM analysis, QS and R2* were also used for
monitoring iron accumulation in sub-cortical gray matter. Localization and quantification
of sub-cortical iron has the potential to enhance our understanding of the progressive loss
of neuronal function, motor deficits and cognitive impairment which accompany MS
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disease progression (12).
In summary, the purpose of this study was to evaluate the potential of quantitative
susceptibility (QS) and apparent transverse relaxation rate (R2*) mapping as surrogate
biomarkers of clinically relevant, age-adjusted demyelination and iron deposition in MS
patients.

5.2 Materials and Methods
5.2.1 Imaging Protocol
Informed consent was obtained from a population of 25 patients with either CIS (four
patients) or RRMS (21 patients), as well as from 15 healthy, age and gender-matched
volunteers. The research was approved by the Research Ethics Board of the University of
Western Ontario. All subjects gave written consent. The mean age of patients was 37.3,
with ages ranging from 21 to 45. Patients had Kurtze Extended Disability Status Scale
scores (EDSS scores) extending from 0 to 6. All CIS patients had an EDSS of 0. Further
information characterizing the patient cohort is listed in Table 5.1 on the following page.
Imaging was performed on a 7 T neuro-specialized MRI scanner (Agilent
Technologies, Santa Clara, California) using 16 parallel transmit channels and either 16
or 23 channel receive coils. Main external magnetic field (B0) (13) and radiofrequency
transmit field (B1+) shimming (14) were performed on each subject prior to acquisition of
the following sequences: (i) a 3D multi-echo GRE sequence (0.5 × 0.5 × 1.25 mm3
resolution) to obtain susceptibility-based images (ii) a T2-weighted, magnetizationprepared (MP)-FLAIR sequence (1.0 × 1.0 × 1.0 mm3 resolution) for lesion delineation
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Table 5.1: Demographic and Clinical Data. Demographic and clinical data for study
cohort. All data showing error estimates represent mean ± standard deviation. P-values
were computed using a Wilcoxon rank-sum test.

Variable

Controls

Patients

p-value

Number of Participants

15

25

Not applicable

Gender, M/F

3/15

7/25

Not applicable

Age

36.4 ± 6.42

37.3 ± 6.10

EDSS score *

Not applicable

1.70 (0 – 6)

0.58 (Not
significant)
Not applicable

* Data in parentheses represent range of EDSS scores for all patients.
(total scan time = 12 minutes and 1 second) and (iii) a T1-weighted, MPRAGE
acquisition (1.0 × 1.0 × 1.0 mm3 resolution) for anatomical reference and use in tissue
segmentation (total scan time = 5 minutes and 45 seconds). The multi-echo GRE
sequence used the following pulse sequence parameters: axial orientation, TR=40 ms,
TE1=3.77 ms, number of echoes=6, echo spacing=4.09 ms, flip angle=13°, matrix
dimensions=380×340× 102, GRAPPA acceleration factor R=2 along the first phase
encode direction, in-plane resolution=0.5x0.5 mm2, slice thickness=1.25 mm, field of
view=190×170×128 mm3, total scan time=15 minutes and 55 seconds.
5.2.2 Calculation of R2*, LFS and QS maps
From the multi-echo GRE magnitude data, mono-exponential R2* maps were generated
using an interior-point, least squares fitting routine in Matlab (R2013, The MathWorks,
Natwick, MA, USA). To compensate for the influence of confounding background field
gradients, T2*-weighted magnitude data was corrected prior to least squares fitting
according to the method outlined in references (6, 15).
For QS map calculation, raw phase images were temporally unwrapped along the
echo train. Residual phase wraps were then removed in three-dimensions using a region-
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growing algorithm (16). Background field contributions were subsequently removed by
employing the sophisticated harmonic artifact reduction for phase data method (SHARP)
(8) with a spherical kernel radius of 7 mm to generate an LFS map. The QS map was
calculated from the LFS map by employing a k-space based, regularized inversion (7) in
Matlab. Accurate and reproducible QS mapping requires calculation of QS values relative
to a common reference structure. In this study, bilateral regions of interest (ROIs) in
frontal deep WM were used as a reference tissue (10).
5.2.3 Voxel-Wise Statistical Analysis
Voxel-wise statistical analysis was performed by registering the calculated R2*
and QS maps to the MNI-1 mm template using a non-linear registration with the FNIRT
tool in FSL (17). A general, additive linear model (GLM) was then applied to evaluate
statistically significant changes in both R2* and QS on the voxel level. Age was included
as a covariate in the linear model. No interactions between covariates or between groups
were modeled. This was done because the inclusion of interactions in the GLM did not
result in improved fitting of the model to the data. All resulting Z-score maps were
corrected for multiple comparisons using the false-detection-rate technique (18) and
thresholded to include Z-scores with |Z| > 1.0. This threshold was applied to allow for the
visualization of both trends and statistically significant regions in the Z-score maps. The
GLM analysis was also performed with WM lesions removed in order to identify
statistically significant reductions in QS and R2* in the normal-appearing white matter
(NAWM) of MS patients. All image analysis was performed by MRI physics researchers
experienced in neuroimaging and blinded to the clinical information (D.R. and R.S.M.,
with 5 and 33 years respectively, of experience in clinical neuroimaging).
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To investigate the correspondence between damaged WM in the Z-score maps
and MS clinical disease status, the volume of damaged WM satisfying a Z<-2.0 criterion
for both QS and R2* was correlated with three MS clinical metrics: extended disability
status scale (EDSS), time since CIS diagnosis (TSCIS) and time since MS diagnosis
(TSMS). This correlation analysis was performed with and without lesions. The Z<-2.0
criterion has recently been used in the segmentation of “diseased-appearing white matter”
from 2D, T2-weighted FLAIR images of MS patients acquired at 1.5T (19). Also, to
explore possible associations between volume of tissue with elevated iron content and
MS clinical status, the volume of sub-cortical gray matter with Z>2.0 was correlated with
the three MS clinical metrics.
As well as using VBM, we evaluated changes in mean value of R2* and QS in
four sub-cortical GM structures (caudate nucleus, putamen, globus pallidus and
thalamus). Specifically, the strength of univariate correlations between the R2* and QS
signals and the three MS clinical metrics were quantified. To account for age-dependent
increases in these parameters, the effect of age was subtracted from R2* and QS data by
calculating the slope in a regression of both R2* and QS as a function of age for the
controls. All sub-cortical gray matter segmentation masks were calculated using the FSL
FIRST tool (17) applied to the bias-field corrected, T1-weighted magnitude images.
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5.3 Results
5.3.1 Representative 7 T Image Contrasts and Template Registration Examples
Representative images from a 45-year old, female RRMS patient with an EDSS score of
1.0 are displayed in Figure 5.1 on the following page. The top row (A-C) shows the
anatomical contrasts: (A) T1-weighted MPRAGE, (B) T2-weighted MP-FLAIR and (C)
T2*-weighted magnitude image. The bottom row (D-F) presents susceptibility-based MRI
contrasts of the same slice: (D) R2*, (E) LFS and (F) QS maps. Magnified views of a
periventricular WM lesion are displayed in red boxes in the top right hand corner of each
figure. The magnified views of the lesion in Figure 5.1D - F identify deoxyhemoglobinbearing vessels, hyperintense on the R2*-map and hypointense on the LFS map. These are
not visible on the T1- or T2-weighted contrasts. Also visible within the lesion are uniquely
heterogeneous regions of decreased R2* and increased LFS, representing possible edema
or demyelination.
Examples of group-averaged, R2*, LFS and QS maps registered to the MNI-1 mm
template space are presented in Figure 5.2 on page 94. The yellow arrows in Figures 5.2A
and B point to slices through the caudate and globus pallidus where increased R2* is
visible in the group-averaged patient maps compared to corresponding control maps. The
red arrows in Figures 5.2E and F identify areas with reduced absolute values of QS in the
optic radiations of the group-averaged control maps compared to corresponding slices in
MS patients.
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Figure 5.1: Representative MR image contrasts employed in this study. MR images
corresponding to one slice from a 45-year old RRMS patient with an EDSS score of 1.0.
Top row: (A) T1-weighted MPRAGE, (B) T2-weighted MP-FLAIR contrasts and (C) a
T2*-weighted magnitude image. Bottom row: (D) R2*, (E) LFS and (F) QS maps.
Magnified views of a lesion in the periventricular white matter are shown in the red
boxes (top right hand corner of each figure).
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Figure 5.2: Standard space, susceptibility-based MRI contrasts. Examples of nonlinearly registered R2* (Figure 5.2A and B), LFS (Figure 5.2C and D) and QS (Figure
5.2E and F) group-averaged maps in the MNI-1 mm template space. Yellow arrows in
Figure 5.2A and B identify regions of the caudate nucleus and globus pallidus of MS
patients with increased R2*. Red arrows in Figure 5.2E and F display regions with
reduced absolute values of QS in the optic radiations of the group-averaged control maps
compared to corresponding slices in MS patients.
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5.3.2 ROI-based analysis of R2* and QS in sub-cortical gray matter structures
Representative sub-cortical nuclei segmentations overlaid on the T1-weighted image are
displayed in figure 5.3. Figure 5.4 on the following page illustrates that, in all the
segmented sub-cortical gray matter structures, both age-corrected R2* and QS showed
very strong positive correlations (p<0.01) with EDSS. The mean R2* value in the
thalamus and caudate displayed the strongest linear correlations (R=0.57). For QS
mapping, the globus pallidus exhibited the strongest linear correlation with EDSS
(R=0.70). Each data point in Figure 5.4 represents the mean value of R2* or QS in a
particular sub-cortical gray matter structure. Separate data points are plotted for the left
and right brain hemispheres, while the red crosses correspond to the mean values of the
control group.

Figure 5.3: Sub-cortical nuclei segmentations overlaid on the T1-weighted image.
Labels for the left side of the brain are coloured white, while labels for the right side are
coloured gray. Segmentation masks are shown for left and right brain caudate (1 and 2),
putamen (3 and 4), globus pallidus (5 and 6), and thalamus (7 and 8). Segmentation
masks which bled into the ventricles were removed by thresholding of R2* and QS maps.
Table 5.2 on page 97 compares group mean values of R2* and QS in sub-cortical
gray matter to those of controls. The mean R2* of patients increased relative to controls in
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all structures, with the exception of the globus pallidus. The most significant increase in
R2* was observed in the putamen (p<0.001, ΔR2* = 3.80 ± 0.74 1/s). The mean QS value
was also increased compared to controls at the level p<0.008 and below.

Figure 5.4: Scatter plots of R2* and quantitative volume magnetic susceptibility in
MS patients with respect to Expanded Disability Status Scale (EDSS). Each data
point represents the mean value of the quantitative MRI parameter inside one of the
following structures: (A) caudate nucleus, (B) putamen , (C) globus pallidus and (D)
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thalamus. A separate data point is displayed for each hemisphere in each patient. The red
lines represent the mean values of the control group.
The most significant increases in sub-cortical QS were found in the thalamus (p<0.001,
ΔQS = 11.47 ± 4.54 ppb) and globus pallidus (p<0.001, ΔQS = 13.02 ± 5.09 ppb).
Table 5.3 on page 100 compares the strength of univariate correlations between
sub-cortical R2* and QS and the three MS clinical metrics (EDSS, TSCIS and TSMS).
Sub-cortical gray matter R2* and QS most strongly predicted EDSS. However,
associations with TSCIS were found for R2* of the caudate (R=0.40, p<0.01) and globus
pallidus (R=0.47, p<0.001), as well as for QS in the putamen (R=0.38, p<0.01) , globus
pallidus (R=0.42, p<0.01) and thalamus (R=0.47, p<0.031). TSMS was independently
predicted by R2* of the globus pallidus (R=0.39, p<0.01), as well as by QS of the
putamen (R=0.35, p=0.01) and thalamus (R=0.30, p=0.04).

Table 5.2: Sub-Cortical Gray Matter Mean Values of Susceptibility-Based MRI
Parameters Compared to Controls. Mean quantitative R2* and susceptibility in the subcortical GM regions of MS patients compared to healthy, age and gender-matched
controls. All values are mean ± standard error.
Sub-cortical GM Structure

Controls

Patients

p-value

Caudate R2* (1/s)

44.52 ± 2.30

46.93 ± 0.79

0.001

Putamen R2* (1/s)

46.31 ± 0.43

50.11 ± 0.60

< 0.001

Globus Pallidus R2* (1/s)

89.88 ± 1.47

90.65 ± 1.18

0.31

Thalamus R2* (1/s)

39.32 ± 1.73

43.55 ± 0.81

0.004

Caudate QS (ppb)

39.71 ± 2.36

45.43 ± 1.44

0.003

Putamen QS (ppb)

33.65 ± 1.01

42.14 ± 2.07

0.008

Globus Pallidus QS (ppb)

128.49 ± 2.73

141.51 ± 4.30

< 0.001

Thalamus QS (ppb)

25.85 ± 4.03

37.32 ± 2.10

< 0.001
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5.3.3 Voxel-wise analysis for evaluating differences in QS and R2* in MS patients
compared to controls
Figure 5.5 on the following page displays axial-plane, R2*-based, Z-score maps at the
level of the sub-cortical gray matter (Figure 5.5A-C), supratentorial brain (Figure 5.5D-F)
and cortical WM (Figure 5.5G-I). Positive Z-scores (orange/red/yellow areas) in subcortical gray matter suggest elevated non-haeme iron in patients compared to controls
(10, 20). Blue colours represent brain regions with significantly (Z<-1.0) reduced R2* in
white matter lesions. Green colours represent brain regions of patient NAWM with
significantly reduced R2* suggestive of pre-lesional demyelination. Reduced R2* in WM
could also be caused by decreased non-haeme iron in glial cells (21) or by a reduced
overall metabolic demand for oxygen in the capillaries of damaged WM (22). If present,
either of these effects would lead to a slight overestimation of the demyelination response
we observed in our R2*-based Z-score maps. An alternative hypothesis, which is
supported by recent MRI studies of reduced cerebral blood flow in MS (23, 24), is that
slower blood flow and concomitantly increased oxygen exchange in capillaries could
result in increased R2* in WM. If this effect were present, the demyelination effect we
observe would be underestimated (section 5.3.3 is continued on page 100).
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Figure 5.5: R2*-based, axial Z-score maps. R2*-based, axial Z-score maps derived from
generalized linear model analysis of 25 patients compared to 15 age-matched controls.
Blue colours represent brain regions with significantly reduced R2* (Z<-2.0) in lesioned
tissue of patients compared to controls. Green colours represent brain regions of patient
normal-appearing white matter (NAWM) with significantly reduced R2* (Z<-2.0)
compared to controls. Red/orange areas with positive Z-scores indicate brain regions
where patients have higher R2* (Z > 2.0) than age-matched controls. (A-C) are three
representative slices through the sub-cortical GM, (D-F) are three representative slices
through the periventricular white matter and (G-I) are three representative slices through
the cortical white matter. All Z-score maps were corrected for multiple comparisons
using the false-detection-rate technique with a significance threshold of 0.1.
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Table 5.3: Correlations between susceptibility-based MRI parameters and clinical
metrics. Pearson linear correlation between mean MRI-derived susceptibility parameters
in sub-cortical gray matter and MS clinical metrics (time since CIS diagnosis = TSCIS,
time since MS diagnosis = TSMS). The MRI susceptibility parameters were corrected for
age-related increases in iron. Data in parentheses are P values.

MRI-Derived Parameter

EDSS

TSCIS

TSMS

Age

Caudate R2* (1/s)

0.57 (< 0.01)

0.40 (< 0.01)

0.19 (0.18)

0.37 (0.05)

Putamen R2* (1/s)

0.39 (< 0.01)

0.21 (0.14)

0.03 (0.86)

0.48 (0.01)

Globus Pallidus R2* (1/s)

0.50 (< 0.01)

0.47 (< 0.001)

0.39 (< 0.01)

0.52 (< 0.01)

Thalamus R2* (1/s)

0.57 (< 0.01)

0.20 (0.15)

0.06 (0.69)

0.25 (0.21)

Caudate QS (ppb)

0.44 (< 0.01)

0.17 (0.24)

0.06 (0.70)

0.19 (0.32)

Putamen QS (ppb)

0.58 (< 0.001)

0.38 (< 0.01)

0.35 (0.01)

0.39 (0.03)

Globus Pallidus QS (ppb)

0.70 (< 0.001)

0.42 (< 0.01)

0.21 (0.14)

0.59 (< 0.001)

Thalamus QS (ppb)

0.56 (< 0.001)

0.47 (< 0.001)

0.30 (0.04)

0.28 (0.23)

Due to the somewhat conflicting findings in the literature, it is not entirely clear
which direction the white matter venous R2* should shift in MS due to the BOLD effect.
However, we can make an informed estimate of the amplitude of the BOLD-mediated R2*
changes by referring to the work of Jochimsen et al. (25). Using Monte-Carlo simulations
to model T2* relaxation in cerebral venous vasculature, Jochminsen demonstrated that, for
typical white matter vessels with radii of 4 – 32 µm, R2* changes due to hypercapnia
(which approximates the ‘hypometabolic’ state observed in MS) are expected to be on the
order of 0.2 s-1. Such changes are very small compared to the average R2* difference in
white matter we observed between MS patients and controls (5.95 ± 0.73 s-1 ; including
lesions). Based on this

estimate, the BOLD-mediated venous R2* changes are not

believed to have significantly affected our results.
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Two additional factors, derived from the existing literature, suggest the changes
we observed in the R2*-based Z-score maps can be attributed to demyelination. First, the
patterns of negative Z-scores follow the major WM bundles in the same manner as voxelwise maps obtained from myelin-water fraction (MWF) (19, 26) and diffusion-weighted
fractional anisotropy (FA) (27) measurements in MS patients. Since MWF and FA are
principally sensitive to myelin structure in WM (not iron), these similar patterns point to
myelin as the major biological source of the reduced R2*. Secondly, there is mounting
evidence from post-mortem histochemical staining of both healthy (28) and MS NAWM
(29) that phospholipid bilayer components are the major source of disseminated signal
decreases observed on transverse relaxometry-based (R2* and R2) MRI.
The damage to NAWM (green areas) occupies a subset of the total (lesion +
NAWM) WM damage. It is localized to the genu, body and splenium of the corpus
callosum, as well as to the optic radiations and periventricular WM. NAWM damage is
also clearly observed in the cortical WM. Although age was included as a covariate, no
significant, voxel-level age effects for R2* were observed at a false-detection rate
threshold of 0.1.
Figure 5.6 demonstrates axial-plane, QS-based Z-score maps through the midbrain (Figure 5.6A-C), supratentorial brain (Figure 5.6D-F) and cortical WM (Figure
5.6G-I). Since myelin is a diamagnetic perturber which negatively shifts raw QS values
(i.e. heavily myelinated tracts are more diamagnetic), demyelination results in a decrease
in the QS values relative to frontal WM. Blue areas in Figure 5.6 represent lesioned
tissue, while green areas represent damage to NAWM. In Figure 5.6D and E,
significantly (Z<-1.0) reduced Z-scores are visible in the genu and splenium of the
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corpus callosum adjacent to the ventricles. In the superior cortical WM (Figure 5.6G-I),
disseminated regions of reduced Z-score are identified along the midline of the brain. As
was the case for the R2*-based Z-score maps, the NAWM damage highlighted in green
occupies a subset of the total damage. The total volume of NAWM damage with Z<-2.0
for QS was significantly larger than that observed for R2*: the mean (per patient) NAWM
damaged volume from QS was 2126 mm3 but only 175 mm3 from R2*. This suggests that,
for our chosen gradient echo scan parameters, QS may be more sensitive to the full extent
of NAWM damage which precedes lesion formation in MS patients.
Bilateral, statistically significant increases in the QS of patients were observed at
the level Z>2.0 in the globus pallidus and putamen in Figure 5.6A and B. Such increases
were not seen on the corresponding R2*-based maps, suggesting QS was prefentially
sensitive to MS pathology-related iron accumulation in these areas. Figure 5.6B and C
also reveal evidence of statistically significant increases in QS values in the thalamus,
with a particular localization of high Z scores in the pulvinar nucleus.
Figure 5.7 shows axial-plane, Z-score maps illustrating the change in QS as a
function of patient age. Blue areas indicate regions of significant QS decrease as a
function of age, while orange/red areas represent regions of significant QS increase as a
function of age. WM lesions were not found to be co-localized with age-dependent QS
reductions. Figure 5.7A-C demonstrate that QS increases significantly (Z>2.0) with age
in the anterior portion of the globus pallidus in MS patients. Increases in QS with age are
visible in the anterior section of the putamen. Figure 5.7D-I also delineate bilateral
decreases in QS with age in the periventricular WM of the centrum semiovale in MS
patients.
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Figure 5.6: QS-based, axial Z-score maps. QS-based, axial Z-score maps derived from
generalized linear model analysis of 25 patients compared to 15 age-matched controls.
Blue colours represent regions of significantly reduced QS (Z<-2.0) in lesioned tissue of
patients compared to controls. Green colours represent regions of patient NAWM with
significantly reduced QS (Z<-2.0) compared to controls. Red/orange areas with positive
Z-scores indicate brain regions where patients have higher QS (Z > 2.0) compared to agematched controls. (A-C) shows increased Z-scores in the sub-cortical GM structures. (DF) display reduced Z-scores in the periventricular white matter. G-I displays decreased
QS in cortical white matter (blue colours).
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Figure 5.7: Changes in relative magnetic susceptibility as a function of age. These Zscore maps were derived by including age as a covariate in the generalized linear model
statistical analysis. Blue colours represent brain regions with significantly reduced QS
(Z<-2.0) in NAWM of patients as a function of age. Red/orange colours represent brain
regions with significantly increased QS (Z > 2.0) in patients as a function of age. (A-C)
are three representative slices through the sub-cortical GM, (D-F) are three representative
slices through the periventricular white matter and (G-I) are three representative slices
through the cortical white matter.
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5.3.4 Relationships Between QS and R2*–Based Z-score Maps and Clinical Disability
The strength of univariate correlation between the volume of damaged WM (defined by a
Z<-2.0 criterion) and EDSS is presented in Figure 5.8 and the corresponding list of
correlations with clinical metrics is recorded in Table 5.4 on page 107. Each data point in
Figure 5.8 represents a single patient, while red and blue points represent R2* and QSbased Z-score correlations respectively. Figure 5.8A displays the correlation between
total damaged WM volume (lesional + NAWM with Z<-2.0) and EDSS. QS damaged
WM volume correlated with EDSS at the level p=0.02 with R=0.46. However, R2*
damaged WM volume did not increase with higher EDSS (R=0.04, p>0.01). Figure 5.8B
shows the same correlations with WM lesions removed. The volume of QS damaged WM
again correlated with EDSS (R=0.39, p=0.05) but the corresponding volume for R2*
(R=0.12, p>0.01) did not. The volume of damaged WM did not correlate with TSCIS or
TSMS for either QS and R2*. However, the EDSS score was independently predicted by
the volume of sub-cortical gray matter tissue in QS-based Z-score maps with Z>2.0.

106

Figure 5.8: Relationship between volume occupied by significant negative Z-scores
and EDSS. Relationship between the volume occupied by significant negative Z-scores
(as defined by a Z<-2.0 criterion) and EDSS. Each point represents a single MS patient.
Data is shown with lesions (A) and without lesions (B). Red and blue points represent R2*
and QS-based Z-score correlations with EDSS respectively. Only the number of
significant voxels measured by QS correlated with EDSS.

5.4 Discussion
In this paper we examined both R2* and QS mapping of whole brain MS patient white
matter compared to age and gender matched controls using voxel-wise analysis in a
standard template space. By doing so, we demonstrated that computation of the
susceptibility contrasts obtained with gradient echo MRI is an effective method for
quantifying demyelination-related changes in NAWM of MS patient brain. A significant
feature of combined R2* and QS mapping is that a single scan can be used to
simultaneously identify iron accumulation in sub-cortical gray matter and demyelination
in major white matter areas. The 'clinico-radiological' paradox associated with MS (30)
suggests that lesion number and total lesion volume in white matter obtained from
standard imaging are not predictive of clinical disease status. However in this work, with
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QS-based Z score maps, EDSS was independently predicted using the volume of
damaged white matter analysis. We also identified clinically relevant correlations
between mean QS and R2* in individual sub-cortical gray matter structures of MS patients

Table 5.4: Relationships between volume of tissue occupied by significant voxels in
R2* and QS-based Z-score maps and clinical metrics. Pearson linear correlation
between the tissue volume occupied by significant Z-score voxels (either significantly
positive, Z > 2.0, for sub-cortical gray matter or significantly negative, Z<-2.0, for white
matter) and clinical metrics of MS. Data in parentheses are P values, time since MS
diagnosis is abbreviated as TSMS, time since CIS diagnosis is abbreviated as TSCIS.
Volume of Significantly
Affected MS Tissue

EDSS

TSCIS

TSMS

Age

Sub-Cortical Gray Matter, R2*

0.26 (0.22)

0.01 (0.99)

-0.18 (0.39)

0.27 (0.18)

White Matter R2*
White Matter R2* Without
Lesions
Sub-Cortical Gray Matter QS

0.04 (0.84)

0.21 (0.32)

-0.08 (0.67)

-0.13 (0.53)

0.12 (0.56)

0.22 (0.29)

-0.05 (0.81)

-0.10 (0.64)

0.52 (< 0.01)

0.26 (0.19)

0.22 (0.29)

0.50 (0.01)

0.46 (0.02)

0.23 (0.27)

0.21 (0.32)

0.30 (0.14)

0.39 (0.05)

0.16 (0.43)

0.18 (0.39)

0.25 (0.23)

0.17 (0.61)

0.65 (0.03)

0.09 (0.79)

-0.11 (0.74)

White Matter QS
White Matter QS Without
Lesions
T2 Lesion Load

and EDSS, TSMS and TSCIS. The finding that group-averaged, mean sub-cortical QS
values exhibited more pronounced statistical differences compared to R2* maps for the
iron-bearing globus pallidus and putamen supports the specific use of QS as an improved
surrogate biomarker of iron accumulation in MS.
In white matter, the correlation of QS negative Z-score volume (R=0.46, p=0.02,
blue dots) with EDSS contrasted with the lack of correlation for R2* (R=0.04 , p>0.10,
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red dots). This may reflect a greater specificity of QS to WM damage. One possible
source of this increased specificity is that QS is more directly related to myelin
composition because it reflects the degree to which myelin becomes magnetized when
exposed to the main field. In contrast, increased intra-voxel susceptibility variation leads
to incoherent dephasing which constitutes the main source of increased R2*.
In a previous study, Langkammer et al. (31) demonstrated that QS was more
sensitive than R2* in monitoring iron accumulation in sub-cortical nuclei of patients with
CIS and MS. Elevated iron levels were also observed in clinically-definite MS patients
compared to those with CIS. However, voxel-wise analysis was not performed. Nor did
the aforementioned study examine clinical correlations with TSMS and TSCIS. In
population studies, voxel-wise analysis can be very useful in assessing differences in
specific brain locations between patients and controls. For this reason, we believe our
findings have identified a new, viable analysis avenue for QS mapping of MS. For
example, our results showed high positive Z-scores in the QS-based maps in the
thalamus, with notably high values in the pulvinar nucleus. This result supports findings
of a previous study by Lebel et al. (32) which noted the pulvinar demonstrated the largest
percent change of all sub-cortical gray matter structures in MRI phase measurements. It
further suggests iron accumulation in the thalamus is visible at the voxel level when using
group analysis with 7T susceptibility mapping. The accumulation of iron in the thalamus
may play a significant role in thalamic atrophy which has recently been associated with
conversion to clinically definite MS (33).
The patterns of reduced R2* in our Z-score maps are consistent with a previous
voxel-wise analysis which applied MWF to visualize pathological demyelination in
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NAWM of primary progressive MS (PPMS) patients (26). The asymmetric decreases in
the R2*-based Z-score maps in the left hemisphere optic radiations are consistent with
asymmetric patterns of demyelination in the optic tract observed in CIS (30), MS (34)
and

in

related

demyelinating

disorders

such

as

progressive

multifocal

leukoencephalopathy (35). The particular pattern of the asymmetric negative Z-scores
we observed, however, is likely a group-average effect specific to our limited patient
cohort. It is not believed to be a common trend across all MS disease sub-types and
patient cohorts. The voxel-level, age-related decreases in our QS-based Z-score maps
have not been previously reported and were not observed in controls. Larger-scale
clinical studies of MS have independently confirmed that age, as well as duration of
disease, correlate with worsening clinical symptoms (36-38). Our voxel-wise QS results,
combined with the aforementioned clinical data, suggest there is a meaningful
contribution of age to demyelination. With this in mind, age-adjusted EDSS or ageadjusted TSMS as proposed in reference (36) may constitute more precise metrics for
monitoring MS progression compared to the standard, non age-adjusted measures. The
detection of age-related demyelination using QS, but not R2*, implies age-related myelin
loss is more closely linked to magnetic susceptibility properties which govern QS (39)
than to nuclear relaxation of hydrogen nuclei probed by R2*.
There are several limitations associated with our study. First, no MRI data was
collected from the spinal cord because the 7T neuroimaging scanner employed for this
work does not permit spinal cord imaging. Quantitative MRI of the spinal cord using
magnetization transfer ratio and diffusion-weighted MRI has previously identified
correlations with disability that reflect underlying damage to the central nervous system
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(40). It follows that a future direction for related research should involve correlating
susceptibility-based changes observed in the spinal cord at 1.5 or 3T with those observed
in the brain at 7T. Additionally, the underlying biophysical sources of the combined QS
and R2* contrast in MS still require further investigation using combined MRI and postmortem histopathological validation. Our results and the work of others (36-38) seem to
support myelin as the dominant contributor to the QS signal in NAWM. However, further
research is necessary to quantify the additional influence of iron dysregulation due to
oligodendrocyte apoptosis and macrophage activation (21, 39) on the susceptibility
contrasts in MS NAWM.
The relatively small size of our patient cohort is another limitation to this study.
The statistically significant differences in the quantitative MRI parameters reported here
should be verified in future work using a larger cohort of MS patients. Overall, our
findings suggest susceptibility-based MRI would be useful for longitudinal monitoring of
demyelination and remyelination in RRMS.

5.5 Conclusion
QS and R2* maps acquired using standard GRE MRI identify demyelination and iron
accumulation in MS which correlate strongly with clinical disability. Using this
information may allow earlier administration of therapies and monitoring of MS
pathology in-vivo. Voxel-wise QS, rather than R2*, was preferentially sensitive to
monitoring NAWM demyelination and sub-cortical iron accumulation in-vivo. The
volume of damaged white matter tissue identified by QS was predictive of EDSS. The
sensitivity of both QS and R2* mapping to total white matter (lesions + NAWM) damage
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suggests these quantitative contrasts may be useful for long term monitoring of
demyelination and remyelination in MS.
The sixth and final chapter briefly summarizes the research carried out for this
thesis. It also suggests ways of extending this research, emphasizing both technical
developments and clinical applications.
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Chapter 6
Conclusion and Future Directions
The Journey is the Reward.
– Steve Jobs, iSteve

MRI is capable of producing images revealing a vast array of different tissue parameters
(1, 2). Currently, for instance, MRI contrast can be preferentially sensitized to tissue
relaxation properties (T1, T2 and T2*), microstructure (diffusion and susceptibility-based
MRI) and motional properties (blood flow and water diffusion) (3). The work presented
in this thesis has investigated the fundamental relationship between the susceptibility
contrast parameters (R2*, LFS and Δχ) and underlying tissue structure. The research was
carried out using biophysical modeling and correlation with quantitative histology. For
the first time, multiple biophysical modeling schemes were compared in both gray and
white matter for excised rat brain tissue. Additionally, scaling relations were derived for
calculating the reversible, mesoscopic magnetic field component, R2′ , of the apparent
transverse relaxation rate from the orientation dependence in gray and white matter.
An optimal susceptibility processing pipeline was also developed and applied to
the calculation of phase-combined LFS and QS maps obtained using ultra-high field
(UHF) MRI. The processing pipeline was then utilized to monitor myelin and iron
changes in MS patients compared to healthy, age and gender-matched controls by
employing voxel-wise analysis in a standard template space. With the use of QS and R2*
mapping, evidence of statistically significant increases in iron deposition in sub-cortical
gray matter structures, as well as myelin degeneration along the white matter skeleton,
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were identified in MS patients. Equally relevant, the 7 T MS study itself represents the
first use of voxel-wise morphometry in both MS white matter and sub-cortical gray
matter using R2* and QS.
In the ensuing section, we identify future directions for the research documented
in this thesis, with an emphasis on both technical developments and clinical applications.
Two areas of technological development which have the potential for significant
methodological advances in magnetic properties mapping-based MRI are discussed: (i)
the use of susceptibility tensor-based white matter anisotropy assessment (4) and (ii)
combined electric and magnetic properties brain tissue mapping (5). Refinement of these
methodologies could result in an enhanced understanding of brain tissue compositional
changes in vivo. This is directly applicable to quantitative monitoring of demyelination
and remyelination in MS. In terms of clinical applications, some recent results from our
longitudinal MS study are presented which focus on the use of susceptibility-based UHF
MRI contrasts.

6.1 Future directions: Technical Developments
6.1.1 Susceptibility tensor-based MRI as an alternative to diffusion MRI for
monitoring microstructure in MS
Diffusion tensor imaging (DTI) is now a standard method for investigating the
architecture and integrity of white matter pathways in the human central nervous system
(6). DTI uses time-varying, pulsed magnetic field gradients applied at different
orientations to probe the principal direction of water self-diffusion in axons (7, 8). In
doing so, it provides in vivo information concerning pathological processes that can occur
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in white matter. For instance, in MS, it has allowed for detection of changes in water
diffusion directionality in both lesions and normal-appearing white matter (9-11).
However, acquisition of DTI data places considerable demands on MRI gradient
hardware and data interpretation is challenging. In particular, the lower SNR of DTI
scans generally results in significantly lower spatial resolution compared to the highresolution, T1 or T2-weighted images conventionally used in MS diagnosis. DTI scans on
clinical scanners use spatial resolutions of 2 - 3 mm. This is a substantial disadvantage
when monitoring the cellular and sub-cellular environment of MS brain tissue. A larger
voxel integrates processes from multiple biological environments, resulting in difficulty
interpreting data. To date, high resolution DTI has only been performed: (i) in ex-vivo
specimens (12, 13), (ii) using thick slices which sacrifice spatial resolution along the slice
axis of the image acquisition (14) or (iii) by employing increased angular sampling (15,
16).
Susceptibility-tensor imaging (STI) may offer an alternative to DTI in cases
where high resolution and short scan time are required. STI is performed using a
standard, short TR, gradient echo acquisition and relies on the magnetic susceptibility
anisotropy (MSA) of white matter axons, believed to be mediated by the phospholipid
molecules in the myelin sheath (17). A critical assumption of STI, as it pertains to white
matter imaging of the brain, is that the principal axis of the MSA is parallel to the long
axis of axons. With this assumption, the magnetic susceptibility tensor of white matter
can be decomposed into three eigenvalues and their associated eigenvectors, utilizing a
simple matrix eigenvalue decomposition (18). The corresponding eigenvalues can then be
used to estimate susceptibility anisotropy and thus probe myelination. In addition, by
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applying conventional line search-based tracking algorithms from DTI to the STI model,
fiber pathways can be reconstructed.
Currently, only one study conducted in perfusion-fixed, mouse brains at 7 T, has
demonstrated ST images comparable to that achieved with DTI (18). In that study, STI
demonstrated reliable anisotropy assessment and fiber tracking in the corpus callosum,
hippocampal commissure and anterior commissure major white matter fiber bundles. STI
tracts appeared smoother at the edge of the fiber bundles while the major tracking
direction was determined by the eigenvalue with the least diamagnetic susceptibility (18).
However, the STI procedure has not been extended to human scanning. Such an
extension would require improvements in the regularization model applied with the STI
matrix inversion, as well as improvements to the pulse sequence and B0 shimming used
in data acquisition.
Sample rotation also poses a fundamental constraint on STI reconstruction.
Alternative methods have recently been suggested allowing either (i) STI reconstruction
using a small number of head rotations with a cylindrically symmetric susceptibility
tensor (CSST) (19) or (ii) STI reconstruction from a single orientation utilizing a
multipole expansion of the image phase in terms of higher-order moments (20). During
preliminary investigations, the protocols have shown promise but require further
refinement from both an acquisition and mathematical analysis standpoint.
DTI has evolved considerably since its first demonstration nearly fifteen years
ago by Mori et al. (7). With continued improvement in both rapid image acquisition and
B0 shimming and the computational processing of higher-order phase data, STI-based
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techniques (18, 19, 21) have the potential to provide significant complementary
information to DTI fiber tracking.

6.1.2 Combined magnetic and electric tissue properties mapping
Electromagnetic properties tissue mapping (EPTM), which includes susceptibility,
conductivity and permittivity imaging, forms the basis of a new contrast in high-field
MRI which is uniquely sensitive to subtle changes in the microstructure of myelin and the
concentration of ferritin iron (5, 22, 23). A more refined understanding of the
electromagnetic properties of brain tissue, particularly how they change in pathological
conditions such as MS, could allow for more informed diagnosis and treatment.
Presently, work in the high-field MRI community has focused on the concise
mathematical and computational understanding of susceptibility properties that can be
derived from the image phase. A principal area of focus has centered around coupling
standard gradient-echo acquisitions with advanced processing methods to isolate the
volume magnetic susceptibility of tissue from the signal phase (17, 20, 22, 24).
Electric properties tissue mapping (EPTM) is an emerging related field which
focuses on the reconstruction of images depicting both tissue conductivity (σ) and
permittivity (ε) (25, 26). The reconstruction of quantitative conductivity maps has been
given the acronym QCM (5). Its diagnostic utility has been cited in studies monitoring:
(i) heart muscle viability after myocardial infarction (27), (ii) brain tissue changes in
response to stroke (28) and (iii) differences between healthy and malignant tissue in
cancer (29). EPTM methods are also central to MRI RF safety, particularly in high field
MRI where heating can become a concern (25, 30).
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Through Maxwell’s equations, a relationship exists between the conductivity of a
biological tissue (σ) in a strong external magnetic field under the influence of RF
excitation and the complex-valued B1 transmit field (B1+) (25, 26, 31). Initially, it was
believed accurate conductivity estimates were only available when using both the
magnitude and phase of the B1+ field (31). A disadvantage of this is its requiring two
separate scans: (i) a gradient echo, actual flip angle imaging (AFI) sequence to measure
the magnitude of the B1+ field (32) and (ii) a spin echo sequence to sensitively measure
the B1+ phase (31). Acquiring two separate scans in this manner lengthened the
acquisition time and resulted in two images having different geometric and point-spread
function-based distortions. To circumvent this difficulty, recent work has identified the
conditions under which it is possible to reconstruct images of tissue conductivity using
only the phase of the B1

+

distribution (5, 25, 26). Assuming local transmit field

homogeneity, the tissue conductivity can be derived from an appropriate re-arrangement
of the Helmholtz wave equation :

[6.1]
where f represents a filter used to improve SNR in the conductivity map reconstruction, µ
is permeability of the sample, ω represents the Larmor frequency of the tissue and ∠ B1+
is the phase of the RF transmit field (33). For a single channel, quadrature head coil, the
phase of the B1+ field can be approximated by taking half of the phase value acquired at
an echo time of TE = 0 (26). This is advantageous because it simplifies the solution to
equation [6.1] and suggests that both conductivity and susceptibility can be measured in a
single scan utilizing a multi-echo, gradient echo sequence (5).
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Provided the magnitude of the B1+ field is also known from AFI mapping,
permittivity (ε) is an additional parameter that can be calculated using EPTM (26, 34).
Although both permittivity and conductivity offer complementary information to QS
maps, the specific relationship between these variables in human brain has not been
explored. One significant area of interest involves the combined mapping of QCM and
QSM in white matter fibers of the human brain. For a myelinated axon, there is an
approximate phenomenological relation between the radius of the axon and the thickness
of the myelin bilayer (35). If the approximate rate of conduction of an action potential
along an axon bundle is known from QCM, it may be possible to combine this with QSM
to estimate myelin concentration. Further, measurement of co-registered QSM and QCM
maps with minimal image distortion would allow correction of QS maps for spurious
conductivity-induced B1+ phase signal (5). This would result in more accurate
determination of QS in white matter and, ultimately, more accurate determination of
axonal myelination.

6.2 Future directions: Clinical Applications
Applying the existing magnetic properties mapping methods outlined in this thesis to
longitudinal MS imaging and assessment of cortical demyelination patterns could
facilitate detection of more subtle abnormalities preceding gross lesion formation and
brain atrophy. In this section a representative preliminary analysis of serial scan data
from our ongoing longitudinal 7 T MS study is presented. It focuses on: (i) the
quantitative patterns of R2* and LFS changes in white matter lesions over approximately
one year in four representative patients and (ii) the patterns of decreased pial R2* in MS
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patients compared to age and gender-matched controls based on data from the crosssectional study documented in Chapter 5 of this thesis.
6.2.1 Longitudinal Analysis of Magnetic Properties of MS White Matter Lesions
Compared to Standard Clinical Contrasts
A complex sequence of inflammatory and neurodegnerative processes underlies lesion
formation in MS. The disappearance and subsequent re-appearance of white matter
lesions on serial T2-weighted MR images of RRMS patient brain is a trademark feature
which has been linked to clinical relapses and subsequent periods of remission. However,
observation of lesion dynamics on serial T1 and T2-weighted MRI scans has not offered
significant predictive power toward understanding disease progression. One possible
explanation is that standard MRI contrasts only visualize a fraction of the disease burden
(in both gray and white matter) which exists in MS. Standard T1 and T2-weighted
sequences employed in clinical trials and routine follow-up assessment usually fail to
identify transient white matter lesions. This is because, during remission phases of the
RRMS disease, lesions on T2-weighted scans can appear isotense compared to
surrounding normal white matter. This confounds assessment of total lesion burden.
An alternative to single time point lesion number or lesion volume-based
assessment is time-series modeling of the MRI signal within a lesion. Serial MRI of MS
patients has identified that, in the short time period (≤ 1 year) following contrast
enhancement, distinct phases of increased and decreased signal intensity appear in
concentric patterns around the centre of white matter lesions (36, 37). More specifically,
Meier et al. (37, 38) demonstrated that, for selected white matter lesions, a sigmodfunction mathematical model of two competing processes (degeneration and repair) could

124
partially explain the temporal evolution of lesions. The time-series modeling approach
also has the potential to detect how drugs target specific phases of disease evolution, thus
enhancing the assessment of drug treatment efficacy.
However, time-series modeling using standard T1 and T2-weighted clinical scans
is non-quantitative and inherently challenging due to the presence of coil sensitivity and
bias field offsets which can change across RF coils and MRI scanners. Moreover, it is
very difficult to assign the signal change on T1 and T2-weighted images to specific
inflammatory or repair processes occuring in MS at the cellular level. In this regard, the
sensitivity of the quantitative susceptibility-based MRI contrasts to iron and myelin may
offer an improved picture of the biological changes occuring across time within MS
lesions (39, 40).
To perform a preliminary investigation of the potential of the susceptibility
contrasts for longitudinal monitoring of lesion dynamics, serial scans taken at four
months intervals over one year for RRMS patients enrolled in the ongoing, longitudinal
7 T MS imaging study at the Robarts Research Institute were analyzed. The four
contrasts employed for this analysis included two non-quantitative MRI contrasts (T1weighted MPRAGE and T2-weighted MP-FLAIR anatomical images), as well as two
quantitative MRI contrasts (R2* and LFS). Seventy-six lesions were selected in four
RRMS patients on the basis of their appearance on all four MRI contrasts for at least one
time point in the serial images. A manual segmentation was initially performed around
the edge of lesions on the LFS maps in each slice. The resulting binary, 2D segmentation
masks were subsequently converted to 3D lesion masks by merging connected
components. For each patient, all images were affine-registered to the high-resolution
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GRE image corresponding to the patients’ most recent visit. The mean and standard error
in R2* and LFS of the lesions on each visit were then computed.
Figure 6.1 on page 128 displays the results of the above analysis. Over the full
eight to twelve month time course for each patient, distinct changes in mean R2* and LFS
are visible. Figure 6.1a demonstrates the results for a 46 year-old female RRMS patient
with an EDSS score of 1.0. The reduction in R2* and positive, paramagnetic shift in the
LFS can be interpreted as demyelination occuring over a 12 month period. All of the
seven lesions identified for this patient followed the same pattern of steadily reduced R2*
and increased LFS (Note that this is LFS relative to frontal white matter). Although iron
might be present in these lesions, iron increase would generally be coupled with
increased R2* and this is not observed.
Fig. 6.1b displays imaging data taken from a 40 year-old female RRMS patient
with an EDSS score of 1.5 and 18 uniquely identified lesions. In the majority of lesions,
R2* decreased during the period from zero to four months, followed by a steady increase
to the one year time point. When coupled with the patterns seen on LFS, this result is
interpreted as demyelination in the first four months, followed by increased iron
deposition between four months and one year. A justification for this interpretation is the
combined increase in R2* and the paramagnetic shift on LFS between four months and
one year.
Figure 6.1c presents serial imaging data taken from a 34 year-old male RRMS
patient with an EDSS score of 1.0. For the majority of the 26 lesions, the R2* slowly
increased, then decreased. The local frequency shift showed a distinct increase from zero
to four months, followed by a subsequent decrease. Such a result can be interpreted as a
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period of remyelination from zero to four months followed by demyelination occuring
from the four month to one year time points.
Fig. 6.1d demonstrates serial imaging data for a 38 year-old male RRMS patient
with an EDSS score of 1.5. For this patient, in the majority of the 25 lesions, the mean
LFS increased, then decreased over an eight month period. However, the R2* value in
lesions steadily increased between zero and four months, then leveled off. This result
suggests accumulation of iron in macrophages and glial cells around the lesion in the zero
to four month period, followed by subsequent remyelination and a resultant diamagnetic
shift (decrease in the relative LFS signal).
In Figure 6.2 on page 129, changes in lesion visibility on the four MRI contrasts
acquired from a 38 year-old male RRMS patient with an EDSS score of 1.5 are displayed
as serial images. Enlarged views of two selected lesions (highlighted by blue and yellow
arrows) are shown in Figure 6.3 on page 130. Three trends are apparent: (i) diffusely
reduced R2* and paramagnetically shifted (darker colours) LFS appear in some lesions
prior to lesion visibility on T1 or T2-weighted scans (yellow arrows), (ii) some chronic
lesions which are persistent across all scans on T1 and T2-weighted images show
decreases in R2* over the 8 month time course (blue arrows), (iii) not all R2* visible
lesions are observed on corresponding LFS maps. For instance, the lesion indicated by
the red arrow in the R2* map is not visible on the corresponding LFS map.
The finding that subtle changes on R2* and LFS can precede lesion appearance on
T1 and T2-weighted images suggests these contrasts could improve the monitoring of
relapsing-remitting lesions. The progressive reduction in lesion R2* over the course of
eight months, highlighted by the red arrow in Figure 6.2c, suggests that, in chronic
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lesions where little to no dynamic changes are observed on T1 or T2 –weighted images,
R2* may be useful for quantifying the subtle microstructural changes to myelin and
axonal integrity that are occuring.
It should be underlined that this preliminary data requires further validation by
incorporating a larger number of lesions in RRMS patients with varying EDSS scores. As
well, due to the lack of contrast-enhanced imaging in our 7 T study, it was not possible to
determine when a lesion first appeared. Using clinical scans acquired at the time of the
first diagnosis for these patients may allow approximation of lesion age and improved
stratification of white matter lesions into those which have persisted over time, those that
have undergone transient signal intensity changes over time and those that have newly
appeared in white matter during the course of the 7 T study. A goal for future analysis of
the longitudinal imaging data from the 7 T MS imaging study is to characterize the R2*
and LFS signal changes into specific lesion types, such as transient T2 enhancing lesion,
transient T1 black holes and chronic T1 black holes. Further research will also incorporate
QSM analysis of both lesions and surrounding white matter.
6.2.2 Cortical R2* Mapping in MS Patients
Recently, there has been a surge of interest in MRI-based evaluation of cortical sub-pial
demyelination using such quantitative techniques as magnetization transfer (41) and T2*based imaging (42). This interest has been fueled by the increased spatial resolution and
improved SNR provided by high-field MRI in combination with conformal, multichannel receive RF coils (43). Several post-mortem studies have noted a frequent and
wide-ranging influence of cortical demyelination in MS (44, 45). To date, however, there
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Figure 6.1. Temporal evolution of the mean R2* and LFS signal within RRMS white
matter lesions over the course of the first year of the longitudinal MS imaging study.
(a) corresponds to a 46 year-old female patient with an EDSS score of 1.0. (b)
corresponds to a 40 year-old female patient with an EDSS score of 1.5. (c) corresponds to
a 34 year-old male patient with an EDSS score of 1.0. (d) corresponds to a 38 year-old
male patient with an EDSS score of 1.5.
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Figure 6.2. Representative longitudinal images from a select patient with MS. Serial
MR images, taken at four month intervals, for a 38 year-old male RRMS patient with an
EDSS score of 1.5. The yellow arrows point to a lesion in the sub-cortical GM which is
detected before its subsequent appearance on T1 and T2-weighted MRI scans 8 months
after the first scan. The blue arrows indicate a lesion in white matter which is visible on
R2* but not on LFS.
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Figure 6.3. Cropped and enlarged lesions as visualized by UHF MRI. These are
enlarged views of the lesions identified with yellow and blue arrows in Figure 6.2. The
changes in the R2* and LFS contrasts are compared to the standard T1 and T2-weighted
clinical images. Regions of interest (lesions) are outlined in red.

have been few in vivo studies examining the role of subpial demyelination across
different brain regions.
Equally important, the existence of reduced R2* values in patients with MS
compared to age and gender-matched controls has yet to be evaluated. With this in mind,
as part of the 7 T MS imaging study, we examined localized differences in R2* of 25 MS
patients compared to 15 controls along the cortical pial surface utilizing group-averaged
cortical surface renderings generated in the Freesurfer software (46). Decreases in and
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along the cortical surface are characteristic of subpial demyelination. Such changes have
already been observed at 7 T using the magnitude signal in a small cohort of MS patients
(47). Nevertheless, the use of R2* in cortical surface mapping and the reproducibility of
these changes remains unclear. In our study, we evaluated cortical R2* changes to
determine their utility in monitoring MS disease severity and staging.
Figure 6.4 displays statistical differences (-log10(p)) in cortical R2* of patients
compared to age-matched controls. Statistical significance colour maps are overlaid on
the average pial surface from all 25 patients included in the cross-sectional study outlined
in Chapter 5. Reduced R2* in patients compared to controls is represented with blue
colours. Areas of significantly reduced R2* along the pial surface of the cortex may
represent regions of sub-pial demyelination. Reduced R2* is visible: (i) near the
intersection of the post-central gyrus and superior parietal lobule (green arrows, left and
right hemispheres), (ii) in the inferior portion of the pre-frontal cortex (pink arrow, left
and right hemispheres) and (iii) at the interface between the superior frontal and caudal
frontal gyri (yellow arrow, left hemisphere). Red areas indicate regions of significantly
increased R2*, indicative of elevated iron deposition along the pial surface. Elevated R2*
is shown in the caudal frontal sulcus of the left lateral surface (purple arrow, left
hemisphere).
Cortical pathology has previously been examined utilizing high-field (7 T) MRI
with multi-channel receive coils in a small population of MS patients (42). Cortical
lesions were visualized and categorized into sub-types (I – IV) using high-resolution,
multi-slice, 2D gradient echo imaging at 7 T. This work was recently extended to full
cortical surface mapping employing the T2*-weighted magnitude signal projected onto an
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Figure 6.4. Student’s t-test significance (-log10(p)) overlaid on the freesurfergenerated average pial surface for the patient cohort. Significance maps are
thresholded at a level of p < 0.1. Blue areas indicate regions of significantly reduced R2*
for patients compared to controls. Reduced R2* is representative of sub-pial
demyelination and is observed along the post-central gyrus, in the superior temporal lobe
and in the pre-frontal cortex. Red areas indicate regions of significantly increased R2*
which are indicative of increased iron deposition along the pial surface.
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average pial surface (47). However, the T2*-based magnitude signal varies as a function
of receiver coil sensitivity, field strength and B1 and B0 shimming protocols (48). In our
study, areas of significantly reduced quantitative R2*, independent of receiver coil
technology and B1 or B0 shimming, were observed along the pial surface in brain regions
associated with sensorimotor, memory and cognitive function. In particular, reductions in
Figure 6.4 are seen in the motor region near the intersection of the post-central gyrus and
superior parietal lobule (Figure 6.4, green arrows, left and right hemispheres), in the
inferior portion of the pre-frontal cortex (Figure 6.4, pink arrow, left and right
hemispheres) and at the inferface of the superior frontal and caudal frontal gyri (Figure
6.4, yellow arrow, left hemisphere). These results are consistent with a previous report
(47) of heightened T2* in the sensorimotor regions, near the left parsopercularis and in the
superior parietal lobe.
In contrast to the previous study (33), however, our data showed no significant
changes in T2* (R2*) in the lateral occipital lobe but did show R2* reductions in the prefrontal cortex. Such differences may reflect differences in the imaging parameters used in
each study (2D, single-echo FLASH imaging was used by Cohen-Adad et al. with a
resolution of 0.33 × 0.33 × 1 mm3 , while our study employed 3D, multi-echo FLASH
with 0.5 × 0.5 × 1.25 mm3). The differences may also be characteristic of the different
patient cohorts. Cortical mapping of R2* in a larger patient cohort combined with
longitudinal analysis is presently underway to verify changes observed in our study and
relate them to clinical disease status.
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